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1and contraceptive method failure. ECPs are also given as 
primary prevention of unintended pregnancy in case of 
rape. Hence, timely access to this safe, effective option 
remains an essential element of women’s quality repro-
ductive healthcare. 
Yet ECPs remain inaccessible in many developing 
countries, especially in sub-Saharan Africa where many 
factors continue to undermine the ability of women to ac-
cess and use ECPs. This toolkit is based on a theoretical 
framework that was developed from a thorough review 
of the available evidence from the EC mainstreaming 
activities implemented by the Population Council, MOH, 
and PSI. 
Audience
The primary target groups for the toolkit are policymak-
ers and health care providers. It can also serve as a 
resource for trainers (for both pre-service and in-service 
students), researchers, RH program managers, and tech-
nical advisors who organize or facilitate training events 
and advocacy workshops for emergency contraception 
activities, advocates, lay community members, media, 
and donors. The toolkit can be used in countries where 
ECPs are not currently available, as well as in contexts 
where the intention is to expand or mainstream access 
to existing ECP services. The toolkit is generic and could 
be adapted by countries, institutions, and individual 
health care providers wishing to mainstream emergency 
contraception services in their respective settings.
The structure
The toolkit is divided into eight sections:
• Section A provides the conceptual framework on 
mainstreaming of emergency contraception activities 
within the public and private sectors. 
• Section B addresses justification and guiding prin-
ciples. 
In late 2006, the Kenyan Ministry of Health (MOH), the 
Population Council, and Population Services Internation-
al (PSI) launched an initiative to mainstream emergency 
contraception (EC) in Kenya. The initiative included a 
core set of activities aimed at improving overall aware-
ness of emergency contraception across the country 
and strengthening the quality of EC services in both 
the public and private sectors. It was intended to serve 
as a model for other countries interested in improving 
access to EC, and to generate in-depth knowledge on 
EC program strategies and utilization characteristics in 
sub-Saharan Africa. 
By the conclusion of the initiative, sales of EC in the 
private sector had more than tripled and public sector 
utilization also increased tremendously. Overall knowl-
edge among providers increased significantly over the life 
of the initiative. Provider capacity also increased in the 
private sector through an innovative, noninvasive strat-
egy to improve information provision in pharmacies. Pre-
service training curricula for nurses and clinical officers 
were updated to include EC, and the MOH drew lessons 
and experiences from the initiative to substantially revise 
the EC component of the 2010 National Family Plan-
ning Guidelines for Health Providers (2010) among other 
achievements.
Toolkit
This toolkit on mainstreaming emergency contraception 
in developing countries has been developed in response 
to one of the objectives of the 2006 initiative that sought 
to generate lessons that could serve as a model for other 
countries interested in improving access to EC, and to 
generate in-depth knowledge on EC program strategies 
and utilization characteristics in sub-Saharan Africa. 
As has been pointed out in many publications, includ-
ing those produced by the International Consortium on 
Emergency Contraception (ICEC), for many women, emer-
gency contraceptive pills (ECPs) offer an opportunity to 
prevent unintended pregnancy following unprotected sex 
OVERVIEW OF THE TOOLKIT AND STRUCTURE
2• Section C focuses on purpose and steps involved in 
mainstreaming EC. 
• Section D outlines the institutional framework re-
quired to successfully mainstream EC activities. 
• Section E discusses effective management of EC 
logistics. 
• Section F addresses supervision and monitoring 
activities.
• Section G focuses on key programmatic considera-
tions; and 
• Section H contains appendices, which are the main 
products of the EC mainstreaming work.  
The appendices appearing in Section H are as follows:
A.1 - Project Overview and Summary of Results
A.2- Health Care Providers Quick Reference Guide
A.3- Selling Protocol for Emergency Contraception Pills
A.4 - Job Aid for Bridging EC Users to Other RH Services
A.5 - Hormonal Emergency Contraception
A.6 - WHO Fact Sheet on Emergency Contraception
A.7 - MOH Monthly Supervision and Monitoring Tool
A.8 – Key M&E Indicators for FP Commodities/EC Pills 
The CD-ROM includes:
Some of the bulky reports such as the final EC main-
streaming report, the follow-up project report, and 
publications.
Abbreviations and Acronyms
AIDS Acquired Immuno-Deficiency Syndrome
APHIA AIDS, Population and Health Integrated  
 Assistance
BCC Behavior Change Communication
BScN Bachelor of Science in Nursing
CBD Community-Based Distributor
CHW Community Health Worker
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CTU  Contraceptive Technology Update
DCMCH Diploma in Clinical Medicine and  
 Community Health
DHS  Demographic and Health Survey
DMPA Depot-medroxyprogesterone acetate
DRH  Division of Reproductive Health
EC  Emergency Contraception
ECP  Emergency Contraceptive Pill
FP  Family Planning
GBV Gender-Based Violence
HIV  Human Immuno-Deficiency Virus
ICEC  International Consortium for Emergency  
 Contraception
IEC Information, Education, and Communication
IUD  Intrauterine Contraceptive Device
KDHS Kenya Demographic and Health Survey
KEMSA Kenya Medical Supplies Agency
LMIS Logistics Management Information System
M&E Monitoring and Evaluation 
MCH  Maternal and Child Health
MIS  Management Information System
MOH Ministry of Health
MOPHS Ministry of Public Health and Sanitation
NGO  Nongovernmental Organization
OTC Over-the-Counter
PEP  Post-Exposure Prophylaxis
PRC  Post-Rape Care
PSI Population Services International
RH  Reproductive Health
SGBV  Sexual and Gender-Based Violence
SPA Service Provision Assessment
STI  Sexually Transmitted Infection
SRH  Sexual and Reproductive Health
TA  Technical Assistance
UNFPA  United Nations Population Fund
VCT  Voluntary Counseling and Testing
WHO  World Health Organization
3In late 2006, Kenya’s Ministry of Health 
(MOH), the Population Council, and Popula-
tion Services International (PSI) launched an 
initiative to mainstream emergency contra-
ception (EC)* in both the private and public 
sectors of Kenya. The specific objectives of the 
initiative were to: increase knowledge, awareness, and 
use of EC among Kenyan women aged 18–30 years; 
increase knowledge and awareness of EC among health 
care providers; and strengthen EC provision in both the 
private and public sectors. When the initiative concluded 
in 2009, sales of EC in the private sector had more than 
tripled, and public-sector utilization had also increased 
tremendously. 
Overall knowledge among providers increased signifi-
cantly over the life of the initiative, and those trained in 
EC demonstrated more favorable attitudes and practices 
toward EC. Provider capacity also improved in both the 
private and public sectors. The results of the project were 
disseminated to policymakers, media, donors, and pro-
gram managers in June 2010. The Council was awarded 
a follow-up project for the period January 2010 to Sep-
tember 2012 to institutionalize and sustain the achieve-
ments realized under this initiative and to promote the 
Kenyan experience as a model for other countries in 
sub-Saharan Africa. Thus, the rich experiences gained 
and the materials used in mainstreaming emergency 
contraception activities within the National Reproductive 
Health and Family Planning programs in Kenya, including 
the follow-up project, have been compiled into a toolkit 
for use by health care providers working in developing 
country contexts. 
The toolkit is generic and could be adapted by coun-
tries, institutions, and individual health care providers 
wishing to mainstream emergency contraception activi-
ties in their respective settings. The toolkit is divided 
into eight sections (A, B, C, D, E, F, G, and H). Section A 
provides the conceptual framework on mainstreaming 
of emergency contraception activities within the public 
and private sectors. Section B addresses justification 
and guiding principles. Section C focuses on purpose and 
steps involved in mainstreaming EC. Section D outlines 
the institutional framework required to successfully 
mainstream EC activities. Section E discusses effective 
management of EC logistics. Section F addresses super-
vision and monitoring activities. Section G focuses on key 
programmatic considerations while Section H contains 
appendices (key products of the EC mainstreaming work).
INTRODUCTION
* Emergency contraception (EC) refers to several contraceptive methods that can be used to prevent pregnancy after sex, including 
emergency contraceptive pills (ECPs) and intrauterine devices. They offer women an important second chance to prevent pregnancy when 
a regular method fails, no method was used, or sex was forced. ECPs must be taken within 120 hours of intercourse, however, the sooner 
they are taken, the more effective they are. Thus, the three types of ECPs are: combined ECPs containing both estrogen and progestin, 
progestin-only ECPs, and ECPs containing an antiprogestin (either mifepristone or ulipristal acetate). 
4The conceptual framework shown in Figure 1 has been 
constructed from the experience and evidence acquired 
mainly from 2006 when an initiative to mainstream 
emergency contraception (EC) was launched. Available 
frameworks (including those developed by FIGO and the 
World Health Organization) do not address programmatic 
aspects of mainstreaming emergency contraception in 
developing countries. Rather, they are confined to as-
pects such as mainstreaming emergency contraception 
within gender contexts or mainstreaming family planning 
within sexual and reproductive health (SRH) activities. 
The framework shown below highlights the challenges 
addressed by the program over the years, project 
objectives, interventions carried out, and their effects 
or outcomes. Interventions included raising awareness 
through the mass media, the use of job aids, IEC materi-
als, weekly updates on EC by retailers, development of 
a Quick Reference Guide, engaging leadership in EC 
mainstreaming, organizing for pre- and in-service train-
ing, and ensuring stock sustainability, among many other 
approaches shown in Figure 1.
SECTION A  CONCEPTUAL FRAMEWORK FOR 
 MAINSTREAMING EC









High proportion of •	
births mistimed 
or unwanted 
Use of EC can •	
reduce unwanted 
pregnancies 
Access to EC •	
limited (low pro-
portion of women 
“ever heard” or 
“used”) 
Limited capacity •	
within public and 
private sectors 
(low proportion 
of health care 
providers trained 
on EC use)
Pharmacists ex-•	
pressed need for 
more information 
on EC
Less than 5% •	
of health care 
providers cor-
rectly identified 
timeframe for EC 
Misinformation •	
and negative 
media coverage
Awareness and use of ECPs increased •	
drastically between 2003 and 2009
Media campaigns were effective in  •	
disseminating key messages on EC
A youth hotline increased users of EC •	
services
Sales of 4 major EC brands increased •	
three times over project life
Pharmacy staff improved provision of •	
basic information on ECPs to clients
Pharmacy staff can effectively use job •	
aids to offer quality EC services
EC can now be obtained at all service •	
delivery levels
Expanded list of persons to dispense •	
EC including trained CHWs/CBDs
Trained providers now counsel/pro-•	
vide ECPs and have more favorable 
attitudes
The EC selling/dispensing protocol ap-•	
proved by local pharmaceutical society
An ongoing South-to-South collabora-•	
tion
Previous experience/evidence served •	
as a basis or model for other coun-
tries’ plans
Increase  
knowledge and 
use of EC  
among women 
aged 18–30 
Strengthen the 
provision of EC 
in the private 
sector 
Strengthen the 
provision of EC 
in the public 
sector
Promote  
lessons 
learned/
experience 
as a model 
for improving 
access to EC in 
the region
FigURE 1 CONCEPTUAL FRAMEWORK FOR MAINSTREAMING EMERGENCY CONTRACEPTION  
ACTIVITIES AT COUNTRY LEVEL 
Raising awareness through:
Mass media campaign on radio, TV•	
Point-of-sale materials in pharmacies •	
Community outreach campaigns•	
A youth hotline (One2one hotline)•	
Private sector interventions included 
the use of three simple approaches:
Job aids with three key messages in •	
English and local language
IEC materials: brochures and posters •	
Weekly updates on EC by retailer•	
Public-sector interventions included: 
Use of a Quick Reference Guide•	
Engaging leadership in EC main-•	
streaming 
Organizing for pre- and in-service •	
training
Ensuring stock sustainability•	
Strengthening EC in national FP •	
guidelines 
Sustainability interventions included: 
Institutionalizing the EC initiative•	
Providing support to the private •	
sector 
Leveraging additional support for EC•	
Using evidence as a model for region•	
CHALLENGES OBJECTIVES INTERVENTIONS EFFECTS/OUTCOMES
5Justification
Emergency contraception, sometimes referred to as 
“morning after” or post-coital contraception provides a 
second chance for women who experience contraceptive 
failure or do not use a method, as well as for women who 
experience unplanned intercourse, including coerced 
sex or rape. Knowledge of emergency contraception 
is crucial, since women must know they can prevent 
pregnancy after intercourse in order to seek care. While 
rates of unwanted pregnancy vary in different countries 
and among population groups, the need for emergency 
contraception is critical especially in developing coun-
tries. Examples of contraceptive failure or incorrect use 
are shown in Box 1. 
Despite the demonstrated safety and efficacy of 
emergency contraception, its acceptance by providers 
and the public, and its inclusion on the WHO’s essential 
drug list, emergency contraception is not widely available 
in many developing countries.1 Contrary to the perceived 
benefits of EC, in a recent article Durrance2 concludes 
that increased access to EC in Washington State had 
no impact on abortion rates and resulted in higher STI 
rates (specifically gonorrhea). Similar findings have, in 
the past, been challenged by other researchers. For in-
stance, in response to an earlier article published in the 
Journal of Health Economics the authors criticized what 
they termed a “dubious association” between OTC ac-
cess to EC and STI rates in the UK.3 The authors argued 
that the pharmacy access program itself may have led to 
significant increases in rates of STI screening, (through 
greater detection of gonorrhea), rather than improved 
access to EC leading to riskier sexual behavior. In addi-
tion, they also observed that the population-level effect 
of EC on abortion rates may be unrealistic, particularly 
since many acts of sex are unprotected and EC is not 
always used. 
Because EC prevents unwanted pregnancies, efforts 
to mainstream the method could be justified on the 
grounds that its use could be seen as an intervention 
to reduce maternal morbidity and mortality associated 
with unsafe abortions and other causes. Abortion is a 
frequent consequence of unintended pregnancy and, 
in the developing world, can result in serious, long-term 
negative health effects including infertility and maternal 
death. Regardless of the cause, unintended pregnancy 
and its negative consequences can be prevented by 
access to contraceptive services including emergency 
contraception. Addressing unintended pregnancy and its 
substantial human and dollar costs should be a priority 
SECTION B  JUSTIFICATION AND GUIDING  
 PRINCIPLES
• Condom breakage, slippage, or incorrect use; 
• Three or more consecutively missed combined oral 
contraceptive pills; 
• The progestogen-only pill (minipill) taken more than 
three hours late (or more than 12 hours late if taking 
a 0.75 mg desogestrel-containing pill); 
• Norethisterone enanthate (NET-EN) progestogen-only 
injection taken more than two weeks late; 
• Depot-medroxyprogesterone acetate (DMPA) proges-
togen-only injection taken more than four weeks late;
• The combined estrogen-plus-progestogen monthly 
injection taken more than seven days late;
• Dislodgement, delay in placing, or early removal of a 
contraceptive hormonal ring or skin patch;
• Dislodgement, breakage, tearing, or early removal of 
a diaphragm or cervical cap; 
• Failed withdrawal (e.g., ejaculation in the vagina or 
on external genitalia); 
• Failure of a spermicide tablet or film to melt before 
intercourse; 
• Miscalculation of the periodic abstinence method, 
or failure to abstain or use a barrier method on the 
fertile days of the cycle;
• Expulsion of an intrauterine contraceptive device 
(IUD) or hormonal contraceptive implant. 
Source:  Levine, Ruth, Ana Langer, et al. 2006. “Chapter 57: Contracep-
tion,” in Dean T. Jamison et al. (eds.), Disease Control Priorities in Devel-
oping Countries, Second edition. Washington, DC: The International Bank 
for Reconstruction and Development/The World Bank, pp. 1975–1990.
BOX 1 ExAMPLES OF CONTRACEPTIVE FAILURE OR INCORRECT USE 
6in every country. Women and adolescents require access 
to age-appropriate and culturally sensitive reproductive 
health care services, including emergency contracep-
tion which is necessary in order to impact the staggering 
maternal mortality rates worldwide.4 
In addition to the health-related arguments in favor of 
the use of emergency contraception, other researchers 
cite other reasons (which are applicable to contracep-
tives in general). For instance, Levine et al.5 state that 
three rationales have underlain policy and programmatic 
interest in contraception, since the 1960s:
• The demographic rationale, typically framed around 
lowering the rate of population growth to achieve 
broad economic, social, and environmental aims, was 
most prominently applied in the 1960s and 1970s. 
By helping to avoid unplanned pregnancies, use of 
emergency contraception contributes to this rationale.
• The fertility rationale, which emerged in the 1980s, 
promoted lower fertility under the assumption that 
smaller families are better off in terms of economic 
and health conditions.
• The human rights rationale, which surfaced in 1994 
at the International Conference on Population and 
Development in Cairo, served as a major force in the 
1990s to focus attention on women’s rights to auton-
omy and empowerment in childbearing and on female 
and male reproductive health. The Cairo Program of 
Action stressed the political and cultural dimensions 
of contraception, including gender issues. In many 
countries, health policies and constitutional provi-
sions stipulate and confer the citizens’ fundamental 
rights to enjoy the highest standards of health care 
including reproductive health. The choice regarding 
whether or not to have children, when to have them, 
or to postpone is part of the broad range of choices 
that exist under the human rights rationale.
In addition, published evidence demonstrates con-
vincingly that making ECPs more widely available does 
not increase risk-taking or adversely affect regular con-
traceptive use.6 In the four studies that examined the im-
pact of easier access to ECPs on rates of sexually trans-
mitted infections, women randomly assigned to a group 
given advance supplies of ECPs for later use should the 
need arise had the same incidence of infection as did 
women in the control group who had to obtain ECPs from 
a clinic. For example, in one randomized trial considering 
the effect of advance ECP provision on regular methods 
of birth control, teens receiving emergency contraception 
supplies in advance were more likely to use ECPs when 
needed but did not report higher frequencies of unpro-
tected sex, did not use condoms or hormonal contracep-
tion less often, and did not exhibit higher rates of STIs.7 
Another study demonstrated that educating teens about 
ECPs does not increase their sexual activity levels or use 
of EC but increases their knowledge about proper admin-
istration of the drugs.8
From a global perspective, EC has yet to reach its full 
potential: many remain unaware that the option exists 
and EC remains difficult for most women to access in a 
timely fashion. Much work still remains to ensure that EC 
is available, especially in developing countries, and that 
unreasonable prescription requirements are re-exam-
ined. Evidence from recent demographic and health 
surveys in sub-Saharan Africa shows that contraceptive 
use is still low and that:
• A high proportion of births (up to 50 percent) are 
mistimed or unwanted. 
• A low proportion of women have “ever heard” or 
“used” EC. For instance, only 40% of women in Kenya 
have ever heard of EC and 1.7% had ever used EC.9
• There is a limited capacity within public and private sec-
tors for counseling about EC and correct provision (low 
proportion of health care providers trained on EC use).
• Misinformation and negative media coverage per-
sist, leading to misuse and stigma among those who 
request a method of EC.
Guiding Principles
Guiding principles for the improvement of health in 
general, and SRH in particular, have been adopted or 
reconfirmed at international assemblies and conferences 
and laid down in international documents including the 
Report of the International Conference on Population 
and Development (Cairo, 5–13 September 1994); and 
the “Overall Review and Appraisal of the Implementation 
of the Program of Action of the International Conference 
on Population and Development,” presented to the Gen-
eral Assembly of the United Nations, 1 July 1999.10
Principles that have guided the development of the 
toolkit are:
• Health is a fundamental human right. Everyone has 
the right to the highest attainable access to health 
care services, including those related to reproduc-
tive health care, which includes family planning and 
sexual health.
• Commitment to the ethical concepts of equity, solidar-
ity, and social justice and to the incorporation of a 
gender perspective in SRH strategies by policymak-
ers, program managers, providers, and other imple-
menters. This includes solidarity in action between 
countries, between groups in countries, and between 
sexes.
• Ensuring that all health services are based on scien-
tific evidence, of good quality, and within affordable 
limits, and that they are sustainable for the future.
7• All couples and individuals have the basic right to 
decide freely and responsibly the timing, number, and 
spacing of their children and have access to informa-
tion and education in order to ensure optimal health 
and informed decisionmaking.
• All people have the right to decide freely and responsi-
bly on all aspects of their sexuality, and have the right 
to be free from conditions that interfere with sexual 
health; sexually acquired conditions including sexu-
ally transmitted infections (STIs) and HIV/AIDS; and 
coercion into having sex and other forms of sexual 
violence.
• The process of initiating emergency contraception 
should be participatory with a broad selection of par-
ticipants or stakeholders.
• The toolkit acknowledges that ECPs are a back-up 
method for unprotected intercourse or contracep-
tive method failure and, as such, represent one of a 
range of contraceptive methods available to national 
programs. Therefore, the introductory process should 
ensure that ECPs are included in the program’s over-
all training materials as well as in the logistics and 
distribution systems.
• Reproductive health care must be responsive to 
expressed needs of the consumers. Individuals have 
both rights and responsibilities in promoting their own 
health and development. Similarly, governments have 
responsibilities for stewardship in the provision of 
health services. 
• The provision of reproductive health services is en-
hanced by policies and programs that promote gender 
equity and equality, empower women, integrate the 
provision of RH/HIV services, and eliminate all forms 
of gender-based violence and discrimination. 
• Gender equity and equality must be addressed at all 
levels of service delivery, including generating and 
sharing information and in monitoring and evaluation 
(M&E) activities. Involvement of men as RH consum-
ers and responsible partners to women will increase 
access to and use of RH services, including preven-
tion of unintended pregnancy.
• There are many providers of EC services besides the 
Ministry of Health (MOH) and its agencies. These in-
clude chemists and pharmacies in the private sector, 
NGO and FBO facilities, other departments of govern-
ment such as the police (e.g., Zambia, South Africa). 
Efforts to improve EC provision within countries 
should consider all the potential stakeholders. 
• The conceptual framework for mainstreaming EC 
activities is not prescriptive; rather it allows each 
country to freely make adaptations to it based on 
the local reproductive health policies and regulatory 
framework.
• Given that the use of emergency contraception 
provides a second chance to women who have had 
unprotected sex, policymakers, program managers, 
regulatory authorities, pharmacy staff, and other 
health care providers should strive to minimize all bar-
riers that could prevent women from accessing and 
using these pills and other products for EC. Given that 
the method using pills is controlled by the woman, 
this autonomy should be respected by society through 
user-friendly information materials and services.
• Introduction of EC mainstreaming activities and roll-
out should be coordinated and integrated with other 
services and programs to capitalize on existing infra-
structure and program efforts especially in the public 
sector. 
8The toolkit is designed to assist policymakers, program 
managers, and health care providers identify the most 
strategic opportunities for introducing EC mainstream-
ing activities in their respective settings and preferably 
within existing RH/FP programs. This toolkit is not de-
signed as a detailed assessment tool. Numerous excel-
lent assessment guides and programming tools have 
been developed to design EC programs and services, in 
the context of larger family planning programs and GBV 
activities. Most of these tools are available from the ICEC 
(www.cecinfo.org), Princeton University (ec.princeton.edu/ 
emergency-contraception.html), and the Population 
Council (www.popcouncil.org).
Intended Audience
Below is an illustrative list of potential country-level 
stakeholders to be involved in the process of main-
streaming emergency contraception:
• Policy decisionmakers and program planners
• Program managers, supervisors, providers of various 
RH services
• Managers of commodity security and logistics
• Key training institutions
• NGO, faith-based, private, and professional organiza-
tions, particularly those focused on family planning 
and other reproductive health activities
• Women’s advocates and advocates for vulnerable 
populations
• Institutions involved in social marketing or other com-
munication initiatives
• Development partners, including donors and technical 
assistance agencies
• Pharmaceutical societies
• Regulatory boards or councils responsible for drug 
registration and pharmacovigilance activities
• Private sector pharmaceutical distributors
• Representatives of chemists and pharmacies
• Producers of EC products
• Health care providers responsible for services de-
signed to reach young people (girls/young women 
particularly), including school and university-based 
health clinics.
Steps Involved in Mainstreaming  
EC Services 
Following proper steps is key to successful develop-
ment and implementation of emergency contraception 
mainstreaming activities. Any country or subnational 
entity wishing to develop an emergency contraception 
program should be guided by the following steps or 
process activities: Preparation and awareness-creation, 
rapid assessment, sharing findings and reaching consen-
sus on priorities, and developing a plan of action. Other 
steps include developing health system tools, training 
providers, introducing emergency contraception pills 
(ECPs), monitoring and supervision, program review and 
evaluation, dissemination of results, and scaling up and 
strengthening program sustainability. These steps are 
detailed in Table 1 below. Although the steps are orga-
nized chronologically, several actions within each broad 
step do overlap and may also be revisited over time.
SECTION C  PURPOSE, TARGET AUDIENCE, AND 
 STEPS INVOLVED
9TABLE 1 STEPS FOR DEVELOPING AND MAINSTREAMING AN EMERGENCY CONTRACEPTION PROGRAM
KEY STEPS DESCRIPTION OF THE STEPS
A. Preparation, advocacy, 
and creation of aware-
ness
This step involves organizing meetings of key persons or officials in the departments responsible for reproduc-
tive health matters including FP and those responsible for registration and regulation of drugs as well as 
distribution of FP commodities. The purpose of this step is to agree on the main issues and next steps
B. Rapid assessment Rapid assessment of emergency contraception service needs, regulatory requirements, and service delivery 
capabilities among other things is a critical step in the provision of information to guide the mainstreaming 
plan for an EC program. Important activities during the assessment include:
Identifying factors that influence patterns of choice and potential use of ECPs in both public and private •	
sectors;
Understanding user perspectives on ECPs and the service delivery system;•	
Identifying the service delivery and managerial adaptations necessary to provide quality ECP services;•	
Assessing providers’ knowledge, attitudes, and practices on EC; and•	
Using the outcomes of these activities to develop national strategies for the introduction and subsequent •	
widespread availability of ECPs.
C. Sharing findings and 
reaching consensus 
on priorities
Involving a broad range of stakeholders to participate in sharing the results of the rapid assessment is an 
important strategy for cultivating ownership. For instance, the pharmaceutical society could make presenta-
tions on findings from the private sector while government officials could make presentations on findings from 
the public sector facilities. 
Findings on user perspectives could be presented by a research institution. This participatory approach also 
presents a good opportunity for identifying various skills among in-country teams. A key step in consensus-
building is for the in-country team to choose the type of EC pill such as Postinor 2 and discuss procurement 
plans. In-country teams are advised to choose products that are already registered in the country.
D. Developing a plan of 
action
After reviewing the findings from the rapid assessment, the next logical step for the in-country teams is to 
develop a plan of action based on the agreed priority activities. In-country teams are encouraged to review the 
conceptual framework (Figure 1) so as not to overlook any sector that is crucial in mainstreaming EC.
E. Strengthening health 
system tools (e.g., 
registers, stock cards, 
others)
In order to track progress regarding the mainstreaming of EC, existing tools—e.g., family planning registers, 
stock cards, reporting forms—will have to be modified or redesigned to incorporate additional columns that 
health care providers will use to enter EC-related data. This step should also include the development of job 
aids or mass media messages for clients on how to use ECPs and where to obtain them, among others.
F. Training providers Providers will need training in issues related to the provision of ECPs, including the special counseling needs 
of ECP clients. Of key importance is ensuring that providers treat women respectfully and maintain a nonjudg-
mental attitude while providing services. The training related to ECP service delivery provides an opportunity 
to strengthen provider knowledge and skills concerning other contraceptive methods; the importance of their 
routine use; and sexually transmitted infections (STIs/HIV risk) assessment, diagnosis, and management. 
Information on ECPs must also be incorporated as part of overall training on family planning, including all 
basic and refresher training for service providers. It must be stressed in all training activities, however, that EC 
does not protect against STIs/HIV or subsequent unprotected intercourse.
G. Introduction and  
distribution of ECPs
This step focuses on introducing ECPs into the market and distributing them through acceptable or author-
ized channels so as to reach clients. In addition to the normal family planning program service delivery 
points, such as MCH/FP clinics and community-based distribution systems, the distribution of ECPs should be 
considered through a variety of other channels. These include private health practitioners, hospital emergency 
rooms, pharmacies, social marketing programs, school or university-based clinics, and sexual assault crisis 
centres.
H. Monitoring and  
supervision
Monitoring and supervision should be conducted routinely to assess key components of the program including 
the functioning of the logistics system, provider activities, whether users are accessing ECPs, and emerging 
challenges, among others.
I. Program evaluation  Evaluation activities should include assessments of user and provider perceptions and experiences with ECPs 
and of the service delivery channels through which they are being provided. Evaluation activities can assist in 
ensuring that ECPs are used appropriately and serve as a bridge to regular FP for clients who require it.
J. Dissemination of 
results
The evaluation results should be disseminated to a broad group of stakeholders.•	
The results should form the basis of developing strategies for scaling up EC provision with emphasis on •	
the need to enhance quality EC services.
K. Scaling up and 
strengthening program 
sustainability
In-country stakeholders will, on the basis of evaluation results, plan for the scale up of EC mainstreaming activi-
ties in other parts of the country so as to increase national coverage. Such a plan has to be agreed upon by 
many stakeholders given its financial and administrative implications.
The interest of in-country stakeholders including MOH in sustaining EC activities is to ensure that current pro-
gram activities and the proposed ones together with the benefits they produce are continued long after the 
initial funding would have stopped, especially from development partners. Hence the need for in-country teams 
to develop sustainable FP programs including EC. Such programs should consider taking into account factors 
such as the need to provide high-quality services, providing management support for activities such as planning 
and supervision, ensuring broad-based commitment by policymakers and public–private partnerships which 
are critical elements in ensuring EC program sustainability.
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Many countries have three levels of health care manage-
ment and coordination. These are national, regional, and 
district levels. The national level is responsible for policy 
and stewardship, the regional level is usually responsible 
for coordination, training, and quality assurance while 
the district level is responsible for managing implementa-
tion. Delivery of health care services also happens at the 
service delivery point and at the community level.
Successful mainstreaming of EC activities at the 
country level has to take into account the potential role 
of national, regional, and district levels and in particular 
how these levels will play complementary and supportive 
roles to each other. These roles are outlined below in 
Table 2 with regard to emergency contraception main-
streaming activities.
SECTION D  INSTITUTIONAL FRAMEWORK AND 
 IMPLEMENTATION MECHANISM
TABLE 2 ROLES OF VARIOUS INSTITUTIONS IN MAINSTREAMING EMERGENCY CONTRACEPTION AC-
TIVITIES BY LEVEL OF HEALTH CARE MANAGEMENT AND COORDINATION
 REGIONAL/PROVINCIAL/ 
NATIONAL LEVEL  COUNTY LEVEL   DISTRICT/COMMUNITY LEVEL
Develop reproductive health policies•	
Provide leadership, advocacy, and coordi-•	
nation of reproductive health activities at 
all levels and among stakeholders.
Establish procedures, and adopt required •	
regulations, standards, and guidelines
Disseminate and distribute policy briefs •	
and discussion papers on emerging EC 
mainstreaming issues 
Advocate for increased funding for RH •	
including family planning activities
Assess the safety, efficacy, and quality of •	
drugs and medical devices
Lead/coordinate/monitor and evaluate EC •	
mainstreaming activities
Organize periodic forums for disseminat-•	
ing results and experiences
Develop training curriculum manuals and •	
advocacy materials on EC for distribution 
at subnational levels 
Supervise•	
Monitor •	
Train•	
Quality assurance •	
Coordinate monitoring •	
and evaluation of EC 
mainstreaming activities
Disseminate national •	
guidelines, policies, 
standards, among 
others
Carry out pharmacovigi-•	
lance activities 
Organize periodic fo-•	
rums for disseminating 
results and sharing EC 
mainstreaming activi-
ties in the region
Facilitate identification of providers dispensing ECPs•	
Assess premises that stock ECPs•	
Organize capacity-building and continuing •	
professional development/in-service training 
Ensure re-supply of ECPs and other family planning •	
commodities 
Provide supportive supervision to health facilities •	
Mobilize local resources to support RH/FP activities•	
Compile monitoring data and produce periodic reports •	
Review community level IEC/BCC materials for •	
relevance and appropriateness
Facilitate dialogue between community and health •	
service providers
Strengthen community involvement in decisionmaking •	
about EC services
Establish a link between the health sector and the •	
community 
Identify cultural beliefs and practices that influence •	
health care–seeking behavior
Quantify requirements for FP including ECPs and •	
place requisitions as per national schedules and 
requirements
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to the following components of inventory control: 
• Determining supply needs (explained below)
• Receiving
• Storing
• Issuing
• Recordkeeping
Determining Supply Needs
Determining supply needs is one of the most important 
steps in inventory management. 
Proper management of any logistics system is to ensure 
that goods including ECPs or services such as counseling 
or information and education reach the intended clients 
at the right time and place. Key messages that are ap-
propriate to many logistics management systems includ-
ing the delivery of ECPs are outlined Text Box 2.
Components of inventory  
management 
Implementation experience has demonstrated that man-
agers involved in procuring, storage, and distribution of 
FP/RH commodities including ECPs need to pay attention 
The logistics •	 six rights provide that good logistics 
deliver: the right product, in the right quantity, in the 
right condition, to the right place, at the right time, and 
for the right cost. The “right logistic management infor-
mation system” to enable the delivery of the six rights 
possible could be considered the seventh right.
The purpose of a logistics management information •	
system is to collect, organize, and report information 
to other levels in the system in order to make deci-
sions regarding the quantity and the time needed to 
distribute drugs, contraceptives, and related medical 
supplies.
Procurement, recording, and reporting are important •	
functions of any logistics management system
All personnel at all levels are important in making the •	
logistics system work effectively.
An effective logistics system will ensure that facilities •	
are adequately stocked at all times and that medical 
supplies including ECPs are available when needed.
If staff carry out their responsibilities to the best of their 
abilities, then the seven “rights” will be achieved.
Components of a Logistics System
Serving the customer•	
Product selection•	
Forecasting and procurement•	
Inventory management•	
Logistics Management Information System (LMIS)•	
Continuous monitoring•	
Items that any logistics management information sys-
tem needs to capture are:
Stock on hand•	 : quantities of usable stock at any level 
of the system (or facility) at a particular point in time.
Consumption data•	 : the quantity of commodities dis-
pensed or used during a particular period of time.
Data on losses and adjustments•	 : the quantity of 
commodities no longer available for use, which have 
not been dispensed/used (e.g., damaged, expired, or 
stolen commodities), and transfers to or from other 
facilities.
*Source: Ministry of Health. 2008.  Integrating Counselling and Test-
ing for HIV into Family Planning Services, National Training Manual, 
1st Edition. Nairobi: Ministry of Health. March.
SECTION E  MANAGEMENT OF FP/EC LOGISTICS
BOX 2 KEY MESSAGES FOR EFFECTIVE LOGISTICS MANAGEMENT SYSTEM FOR ECPS*
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Once the necessary supply needs are identified and 
quantified, the next step is to reconcile these require-
ments with the available financial resources or budgetary 
commitment (from either the government or donors). 
Once this is done then appropriate procurement 
processes are undertaken to facilitate the delivery of the 
commodities. More often the quantities of commodities 
procured under a public-sector program are dependent 
on the availability of financial resources allocated for this 
purpose by ministries of finance. The situation is slightly 
different in the private sector where the quantities pro-
cured or distributed are dependent on potential demand 
for the respective commodity or commodities.
Determining supply needs is done by conducting a 
physical inventory in order to review stock status. Other 
reasons for conducting a physical inventory include:
• Determining how much of each commodity one has in 
the facility,
• Determining how long the stocks will last, and 
• Ascertaining whether the available quantities of 
stocks could last until the next order is received or 
processed.
Frequent review of stocks is important in estimating 
consumption of commodities and supply needs. Estimat-
ing consumption of commodities is done as follows: 
• Calculate average monthly consumption
• Determine months of stock on hand
• Determine order quantity (by estimating maximum 
and minimum stock levels, conducting physical 
counts [stock on hand] and subtracting the balance 
on hand from the maximum stock level to be able to 
obtain the quantity to order).
Monitoring Monthly Consumption of 
ECP Stocks
Monitoring monthly consumption of stock is an impor-
tant step in establishing the quantity consumed or to be 
ordered. Managers involved in procurement, inventory 
control, and distribution of FP/RH commodities includ-
ing ECPs need to be conversant with basic concepts 
concerning months of stock and how to derive maxi-
mum and minimum levels of stocks at different levels 
of inventory control. This is because central, regional, or 
district and health facilities require varying quantities of 
minimum and maximum months of stock. 
Months of stock
This is the number of months supplies will last based on 
the present consumption rate. It is obtained by dividing 
the ending balance per month of stock (e.g., of ECPs) by 
the average consumption of stock (e.g., ECPs) per month. 
Maximum months of stock
It is the largest amount of each commodity a facility 
should hold at any one time.
Minimum months of stock
It is the least amount of each commodity a facility should 
have at any one time.
Examples of the minimum and maximum months of 
ECPs by level of inventory control are given in Table 3. For 
purposes of illustration, only two levels are given, namely 
the central warehouse and the health facility.
Stock card
A stock card or, as it is sometimes called, a bin card is 
an important document that records the status of a good 
or goods held in a store or stockroom. The card helps 
in recording a running balance of stock (in our case the 
ECPs). Thus, the stock card (see an example in Figure 2) 
facilitates accounting for supplies requisitioned. In plac-
es where information is not computerized, it is stored at 
the service delivery point and is completed by the officer 
in charge each time new supplies are received. In places 
where inventory control has been computerized, the 
information on the stock card is updated electronically 
and it is possible to know the balance of the stocks on 
daily basis.  
TABLE 3 MINIMUM AND MAxIMUM MONTHS OF ECPS BY LEVEL OF INVENTORY CONTROL
COMMODITY
LEVEL OF 
INVENTORY CONTROL 
MAXIMUM MONTHS 
OF STOCK
LEVEL OF INVENTORY  
CONTROL 
MINIMUM MONTHS OF 
STOCK
Contraceptives
(ECPs)
Central warehouse 12–15 months Central warehouse 6–9 months
Health facility 4–6 months* Health facility 2–3 months*
* Shorter periods of minimum and maximum months of stock are required to avoid possible losses, e.g., through expiry.
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Supervision
Effective supervision is a critical element of an effective 
Logistics Management System (LMS). Without it, overall 
quality of LMS may weaken, which in turn may jeopard-
ize the quality of service provided to clients. This is the 
process of ensuring that personnel have the knowledge 
and skills required to carry out their responsibilities 
effectively, and to provide immediate on-the-job train-
ing, as needed. Supervision ensures personnel have the 
knowledge and skills they need to effectively manage 
the logistics system and identifies performance weak-
nesses and improves performance through on-the-job 
training as needed. 
Supervision also ensures that that established logis-
tics guidelines and procedures are being followed. The 
team carrying out supervision activities should establish 
that each FP service delivery site including clinics and 
health posts shall: 
• Have a copy of the policy guidelines and service 
standards for sexual and reproductive health. Some of 
these policies also address the provision of EC services. 
• Have a copy of family planning procedures guidelines 
for service providers. National FP guidelines usually 
address issues to do with the provision of EC services.
• Maintain adequate and accurate records of clients 
and commodities. 
• The monthly supervision and monitoring tool for ECPs 
is found in Appendix A.7.
FigURE 2 ExAMPLE OF A STOCK CARD
      Item name:                                                                       Unit:                                                                                                      
      Manufacturer:                                                               
      Kit lot number:                                                               Expiration Date:                                                            
Date Received from Issued to
Quantity 
received
Quantity 
issued *Balance Lot  # Signature
*Balance – perform physical inventory count each month. If physical count does not equal balance, consider causes for discrepancies, e.g., theft, 
expired drugs.
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Monitoring and Evaluation Activities
Efforts for mainstreaming emergency contraception 
are likely to be undermined by two main challenges.  
First, monitoring the use of emergency contraception 
pills by clients in the private sector (including chem-
ists, pharmacies, and clinics) is a difficult task since 
the majority of providers do not maintain good records. 
Second, monitoring the use of emergency contraception 
pills in the public sector is sometimes difficult due to 
low volume used coupled with poor reporting rates by 
health facilities. 
In some countries, FP commodity utilization register(s) 
and gender-based violence registers are the main sourc-
es of data on ECPs in the public sector. In some coun-
tries, the police department or other office in the justice 
system could also serve as a source of data for ECPs, 
especially those stocks used for gender-based violence 
cases. In countries where CHWs/CBDs are allowed to 
distribute ECPs, one could also find utilization data from 
their records. In the private sector, good estimates of the 
use of ECPs at the population level have been derived 
from sales data (obtained from the distributors of brands 
of dedicated ECPs such as Postinor 2).11 
The most likely sources of data for program evalua-
tion are:
a) Demographic and Health Survey (DHS): The DHS is a 
nationally representative household survey that is the 
source of impact and outcome indicators. 
b) Service Provision Assessment (SPA): The SPA is a 
nationally representative facility survey that collects 
information on aspects of out-patient primary care 
(i.e., antenatal, family planning, and sexually transmit-
ted infections) services and providers. 
c) Surveillance: Surveillance is the ongoing, system-
atic collection, analysis, and interpretation of data 
on a disease or health condition from public health 
programs, combined with feedback to all. It is vital for 
guiding the national response. 
d) Evaluations: Evaluations are conducted to gather 
evidence on whether the right interventions are being 
(or were) implemented with recommendations/les-
sons learned and whether the program effects could 
be attributed to specific interventions. 
Pharmacovigilance
Pharmacovigilance refers to the science of collecting, 
monitoring, researching, assessing, and evaluating 
information from health care providers and patients on 
the adverse effects of medicines, biological products, 
herbals, and traditional medicines. Pharmacovigilance is 
an arm of patient care whose aim is to promote patient 
safety by identifying new information about hazards and 
preventing harm to patients. Its scope includes substan-
dard and counterfeit medicines, medication error report-
ing, adverse interactions of medicines, etc. Although this 
activity is usually conducted by regulatory authorities, 
our implementation experience shows that dealing with 
counterfeit ECPs has often required team effort by stake-
holders involved in EC mainstreaming work.
Signs of a poor-quality medical product
Identifying and dealing with counterfeit ECPs (especially 
the dedicated brands) is often a complex exercise. 
However, regular surveillance activities by a team from 
regulatory authorities, law enforcement officers, and 
public health officials, among others, are often effective 
in minimizing this problem. 
Box 3 provides a list of examples of signs of a poor-
quality medical product that does not meet the required 
quality standards in terms of physical appearance, level 
of active ingredients, packaging, and labeling which the 
surveillance teams are likely to look for. Other measures 
such as officials from regulatory bodies (in a country 
where new ECPs are to be registered) visiting manu-
facturing sites to assess whether the firms involved do 
follow strictly good manufacturing practices and periodic 
changes to packaging materials and instructions help in 
addressing quality concerns.  
SECTION F  MONITORING AND EVALUATION  
 ACTIVITIES AND PHARMACOVIGILANCE
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Color changes
Separating of components
Powdering/crumbling
Caking
Moulding
Change of odor
Mislabeling
Incomplete pack
Suspected contamination
Questionable stability
Defective components
Poor packaging/poor labeling
Therapeutic failures (lack of efficacy)
Receiving expired medicines
WHO. 2002. The Importance of Pharmacovigilance - Safety monitoring of 
medicinal products. Geneva: WHO.
Indicators for Assessing Performance 
of FP/ECPs Logistics System
In 2007, the RH Supplies Coalition developed a Moni-
toring and Evaluation Framework 2007–2015,12 which 
contains a list of 30 key indicators for tracking progress 
for RH supplies. In this toolkit, some of the indicators 
have been adapted for use by countries wishing to track 
the EC mainstreaming work. See Appendix A.8 for a full 
list of the indicators, which are organized around specific 
objectives and the following three goals: 
Goal 1: Increase predictability and sustain-
ability of financing for FP/EC supplies
Through this goal, the RH partners, including MOHs aim 
to increase resource flows for FP commodities includ-
ing EC supplies from all sources at the country level. 
Possible sources include donors, consumers, the public 
sector, insurance schemes, and the private sector. 
Goal 2: Strengthen the capacity of health 
systems to sustain FP/EC supplies 
This goal aims to maximize synergies among MOH part-
ners in order to strengthen supply chain systems and en-
sure sustained delivery of a broad range of RH supplies 
including FP commodities. Strengthening the capacity of 
health systems to deliver FP/EC supplies will encompass 
both public and private sector institutions.
Goal 3:  Steer EC mainstreaming activities 
within the broader RH services
This goal seeks to reinforce the capacity of the MOH 
and its partners to advocate for RH supplies security 
(including FP/EC commodities), promote innovation and 
an all-inclusive approach in creating awareness, and in 
conducting advocacy activities. The goal also seeks to 
expand the total market for FP commodities including EC 
pills and identify other sustainable ways of mainstream-
ing EC such as training, policy support, creating aware-
ness at all levels, and integrating EC mainstreaming in 
the broader RH activities.
BOX 3 SIGNS OF A POOR-QUALITY MEDICAL 
PRODUCT
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Awareness and Use of ECPs Increased 
During the Project Period
Awareness and reported use of ECPs increased dramati-
cally over the life of the initiative. In 2003, the KDHS in-
dicated that less than one quarter of Kenyan women had 
ever heard of ECPs.13 In 2007, PSI conducted a baseline 
survey in 13 major towns and peri-urban areas across 
seven provinces, and found similar patterns, with only 
21% of women reporting having ever heard of ECPs and 
5% who had ever used the method. Of those, only 15% 
could correctly identify ECPs as a contraceptive method 
taken after sex to prevent pregnancy. By 2009, 56% of 
women in the same sites had ever heard of ECP and 10% 
had ever used the method.14
Despite huge increases in the proportion of clients 
who had heard of or ever used ECPs, the overall utilisa-
tion rate is still low, indicating the need for continued 
education and awareness-creation. Countries wishing to 
implement EC mainstreaming activities need to appreci-
ate the fact that a major restriction on women’s use of 
EC is their very low rate of awareness of this FP method. 
Because EC is generally accessed at the pharmacy level 
in Kenya women must know about it in order to seek it 
out. In this regard, EC differs significantly in the commod-
ity and supply chain issues from other methods such as 
implants and female condoms which are described in 
detail by the United Nations Commission on Life-saving 
Commodities for Women and Children.15 
The results are consistent with views recently ex-
pressed by Westley and Swartz16 who pointed out that 
EC has yet to reach its full potential in terms of impact. 
EC remains difficult for most women to access in a timely 
fashion, and the most effective methods of EC such as 
dedicated ECPS are even harder to access compared to 
Yuzpe methods. Dedicated ECPs are effective in prevent-
ing up to 95% of pregnancies, and the Yuzpe method is 
effective in approximately 75–80% of cases.
Mainstreaming the Provision of EC in 
the Private Sector 
Findings from the EC mainstreaming project in Kenya 
showed that private-sector pharmacies are the most 
common access point for ECPs. PSI’s 2007 baseline 
survey found that 94% of women who had used ECP 
in the past two years obtained it from pharmacies. In 
2009, their endline survey found that while 83% identi-
fied pharmacies as a place to obtain ECPs, only 25% 
mentioned government clinics.17 In 2008, national-level 
ECP distribution through private sector pharmacies was 
approximately twice that distributed through the public 
sector. Within government clinics, a 2007 record review 
found that 93% of the ECPs distributed in the previous 
18 months were for sexual assault cases.18 This shows a 
possible bias toward the use of EC in cases of sexual as-
sault when compared to other more common indications 
that exist within many public health facilities.
In countries where the coverage of the private sector 
is not significant in health, such biases in the provision of 
EC services by the public sector may imply that women 
wishing to have access to it may not succeed because 
of the limited options other than in cases of sexual 
assault. Therefore, countries wishing to embark on EC 
mainstreaming activities need to plan carefully well in 
advance on how to position ECPs to avoid stigmatizing 
this critical service. 
Given the key role pharmacies play in the provision of 
EC services, evidence shows that when pharmacy staff 
are given basic information on key messages they need 
to give their clients, they did provide the information on 
EC (including when and how to use it, mechanism of ac-
tion, side effects, and efficacy). The pharmacy staff also 
discussed other FP and RH services with clients. These 
results suggest that sales staff at private sector pharma-
cies can deliver more effective EC services when given 
the proper tools. It also indicates that extensive and 
often costly training efforts are not needed to improve 
services within pharmacies.19
Strengthening the Provision of EC in 
the Public Sector 
Four main lessons emerged from the implementation ex-
perience in mainstreaming EC activities in Kenya. These 
lessons (highlighted below) revolve around developing 
simple-to-use reference materials for health care provid-
ers, integrating ECPs into pre-service and in-service train-
ing programs, advocacy activities at the policy level, and 
strengthening of data-capture tools (registers). 
SECTION G  SUMMARY OF KEY LESSONS AND  
 PROGRAMMATIC CONSIDERATIONS
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Materials development for health care  
providers
To support training efforts, a comprehensive PowerPoint 
presentation on EC was developed for trainers as well 
as a booklet, the Health Care Providers Quick Refer-
ence Guide, published as part of a strategy to enable as 
many health care providers as possible to have access 
to user-friendly and updated materials on emergency 
contraception. The booklet was also disseminated widely 
to provincial and district health management teams by 
the MOH and was used as source material for the 2010 
update of the National FP Guidelines. Simple and easy-to-
use materials—especially those that fit into pockets of lab 
coats—are preferred by health care providers. Because of 
its simplified language, the MOH in Kenya also distributed 
thousands of copies of the Health Care Providers Quick 
Reference Guide booklet to members of the public.20  
Integrating ECPs into pre-service and  
in-service training programs 
With minimal resources, modules on ECPs were inserted 
into in-service training packages for use by health care 
providers in Kenya. In addition EC modules were incor-
porated into the Nursing Council’s and Clinical Officers’ 
pre-service training curricula. Incorporating EC into the 
pre-service training curricula ensures that all future 
nursing and clinical medicine graduates will receive 
instruction on ECPs and the strategy was seen as a more 
cost-effective way of sustaining health care providers’ 
knowledge and practice on emergency contraception. 
The approach also promotes the principle that EC should 
be addressed in the context of comprehensive FP/RH 
services rather than as a stand-alone service.
Policy-level advocacy is necessary to ensure 
adequate ECP stocks in the public sector
Under the leadership of the MOH, advocacy efforts 
ensured that ECPs were included in the national con-
traceptive security plan and subsequent procurements. 
For instance in FY 2012/2013 the Government of 
Kenya has allocated approximately Kshs. 976,423,000 
($11,624, 000)21 for the procurement of FP commodi-
ties, which is slightly over twice the amount of funds 
(Kshs. 350,000,000=$5,147,059)22 that was allocated 
by the Kenyan government for the purchase of FP com-
modities during FY 2006/2007 at the beginning of the 
EC mainstreaming activities. These figures demonstrate 
the Kenyan government’s commitment to sustaining the 
procurement of FP commodities using its own funds.
Revision of FP registers and inclusion into 
the Contraceptive Security Strategy
In 2008 the Division of Reproductive Health (DRH) in the 
MOH added a column for ECPs to the revised FP register 
to improve recordkeeping and allow facilities to reorder 
ECPs. Integrating EC into the documents that underpin 
contraceptive security such as the national FP register, 
ensured that EC utilization was properly recorded and 
captured in facility-level stock re-ordering alongside the 
other regular FP methods. Another important accom-
plishment regarding the EC mainstreaming effort was the 
inclusion of ECPs in the national contraceptive security 
strategy, which is intended to limit stock-outs of essen-
tial family planning commodities. This ensures that EC 
programming activities receive the requisite attention at 
all levels alongside the other regular FP methods. 
Ensuring Sustained Impact 
Although PSI’s advocacy campaign was successful in 
generating momentum around EC, at the end of the first 
phase of the EC mainstreaming project (2007–2009), 
stakeholders in Kenya felt that they still required techni-
cal assistance in developing strategies to institutionalize 
and sustain the achievements realized under this initia-
tive. It was on the basis of this request that the Popula-
tion Council, with support from the Hewlett Foundation, 
coordinated the second phase of the EC mainstreaming 
project (January 2010 to May 2012) with a focus on  in-
stitutionalizing key activities to sustain the impact of the 
project. A detailed project description for the follow-up 
phase is found in the CD-ROM. Some of the key achieve-
ments during the follow-up project were:
• Inclusion of EC into the Bachelor of Science in Nursing 
(BScN) syllabus in 2010. The BScN syllabus is admin-
istered by the Nursing Council of Kenya. In 2011, the 
curriculum for the Diploma in Clinical Medicine and 
Community Health (DCMCH) that is administered by 
the Clinical Officers’ Council was revised to incorpo-
rate new topics including EC.
• Strengthening the provision of EC in public-sector 
health facilities by provincial and district level health 
management teams through structured support su-
pervision visits.
• Approval of the EC selling protocol, in February 2011, 
by the Pharmaceutical Society of Kenya (PSK), for 
use by their members to strengthen provision of EC 
services in the private sector pharmacies. 
• Successful completion of a South–South technical 
exchange visit that involved four sub-Saharan African 
countries that were interested in mainstreaming emer-
gency contraception activities. The three-day visit took 
place in early April 2012 and involved health man-
agers from Rwanda, Malawi, Uganda, and Zambia. 
During the meeting, delegates shared experiences in 
mainstreaming EC in their respective countries with 
their Kenyan counterparts. The teams also visited 
private-sector pharmacies (to see how ECPs were 
provided in the private sector) and the Kenya Medical 
Supplies Agency (KEMSA) to familiarize themselves 
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with procurement procedures for FP supplies includ-
ing ECPs, storage, and countrywide distribution of 
these commodities to health facilities.
• The national communications campaign under-
taken by PSI effectively increased awareness of EC 
among the target population. To expand the pro-
gram’s impact with limited resources, the Council 
worked with the MOPHS to ensure that EC mes-
sages are incorporated within the national commu-
nications strategy and that the materials from PSI’s 
national mass-media Tulia campaign continue to be 
used by the MOH.   
Besides these achievements, ensuring a sustained 
impact of EC mainstreaming activities also requires 
that countries focus on the 5Ps of product, price, 
place, promotion, and people so that their product (or 
service) appropriately targets the chosen segment of 
the market.23 
Product. How the product (or service) should 
look and function to meet the needs of the target 
audience(s). This includes considerations of packag-
ing, branding, and product formulation. Dedicated 
EC products are specifically identified for emergency 
contraception and contain appropriate instructions as 
well as the required number of pills for their correct 
use. Specific packaging makes them easier to supply 
through pharmacies and social marketing programs.24 
Price. What the product (or service) costs the direct 
consumer. This price should fit the target audience’s 
ability to pay. In an earlier study in Kenya, the authors 
found out that nearly all university students inter-
viewed were willing to pay for ECPs (Postinor 2) at an 
estimated price of $1 (40 Kenya shillings at the 1996 
exchange rate) rather than risk paying for abortion 
services, which cost  over a hundred times more. The 
price for inducing an abortion was then estimated at 
($100 or 4,000 Kenya shillings at the 1996 exchange 
rate).25 Although ECPs are provided free of charge 
in public-sector facilities, the findings showed that 
availability of ECPs in private-sector outlets could be 
sustained through direct sales of the pills to clients.
Placement. Where the product (or service) is avail-
able. Placement should factor in the type of outlet 
(e.g., clinic, store, pharmacy) but also the operating 
hours of such outlets. Given that some of the private 
sector pharmacies in Kenya operate for 24 hours 
especially in urban areas, clients seeking to buy these 
commodities can theoretically access the services any 
time, compared to the restrictions found in the public 
sector regarding opening and closing hours and the 
unavailability of these services during weekends and 
public holidays (unless in the case of survivors of rape 
or gender-based violence). 
Promotion. What advertising and communication 
channels are used to encourage consumer uptake 
of the product or service. PSI used a mass-media 
campaign on the radio, in print, and on TV (to increase 
awareness and knowledge of EC). In addition, other 
channels included developing point-of-sale materials, 
e.g., brochures to increase clients’ knowledge and 
uptake of regular FP methods). 
People. People need to bring products to custom-
ers or clients. The revised National FP Guidelines in 
Kenya26 allow various cadres of health care providers 
to handle ECPs. These include doctors, nurses, clinical 
officers, pharmacists, pharmaceutical technologists, 
pharmacy assistants, counselors, and community 
health workers, among others. For successful insti-
tutionalization and replication of EC mainstreaming 
activities, as a minimum, each of the persons involved 
in providing EC services to clients ought to emphasize 
these key messages:
• EC can prevent pregnancy after unprotected sex, 
• EC does not protect against HIV or STI infection, and
• EC should be used only as an emergency method 
and not as a regular form of contraception
Other sustainability factors critical to ensuring the 
program’s success are: 
Target-group knowledge, attitudes, and 
practice
The degree to which the principal target groups are 
knowledgeable and motivated to utilize EC services 
and their benefits improves sustainability. Low knowl-
edge, poor motivation, and non-use of services are a 
threat to sustainability.
Service quality
The degree to which high-quality services can continue 
to be provided in the future is an indicator of program 
sustainability. Low quality or the absence of key ser-
vices can be a threat, while high quality may increase 
demand for services and support.
Management support
Management support for activities such as planning 
and supervision enhances the chance of sustaining 
programs. Weak or missing support services can be a 
threat to sustainability.
Policymakers’ commitments
High, broad-based commitment by policymakers is 
conducive to sustainability; low, narrow-based com-
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mitment is a threat. A commitment by policymakers 
ensures the availability of the desired commodity and 
facilitates in-country registration allocation of re-
sources for procurement, distribution, monitoring, and 
supervision activities. Policy commitment also builds 
effective partnerships and facilitates the development 
of appropriate standards, guidelines, and implementa-
tion of appropriate quality assurance activities.
Notes
1 Langer, A., et al. 1999. “Emergency contraception in Mexico 
City: What do health care providers and potential users know 
and think about it?” Contraception 60: 233–241.
2 Durrance, Christine Piette. 2012. “The Effects of Increased 
Access to Emergency Contraception on Sexually Transmitted 
Disease and Abortion Rates,” Economic Inquiry. Western 
Economic Association International.
3 Moreau, Caroline, James Trussell, and Anna Glasier. 2012. 
“Challenging the ‘insurance theory’ of sexual and reproduc-
tive health behaviors,” Journal of Contraception 85(1): 9–10. 
4 Klima, Carrie S. 1998. “Unintended pregnancy: Conse-
quences and solutions for a worldwide problem,” Journal of 
Nurse-Midwifery 43(6): 483–491.
5 Levine, Ruth, Ana Langer, et al. 2006. “Chapter 57: Contra-
ception,” in Dean T. Jamison et al. (eds.), Disease Control 
Priorities in Developing Countries, Second edition. Wash-
ington, DC: The International Bank for Reconstruction and 
Development/The World Bank, pp. 1975–1990.
6 Shaaban, O.M., et al. Forthcoming. “Emergency contracep-
tive pills as a backup for lactational amenorrhea method 
(LAM) of contraception: A randomized controlled trial,” 
Contraception.
7 Gold, M.A., et al. 2004. “The effects of advance provision 
of emergency eontraception on adolescent women’s sexual 
and contraceptive behaviors,” Journal of Pediatric & Adoles-
cent Gynecology (17): 87–96.
8 Graham, A. et al. 2002. “Improving teenagers’ knowledge of 
emergency contraception: Cluster randomized controlled trial 
of a teacher led intervention,” British Medical Journal (234): 
1179–1184.
9 Kenya National Bureau of Statistics (KNBS) and ICF Macro. 
2010. 2008–09 Kenya Demographic and Health Survey. 
Calverton, MD: KNBS and ICF Macro.
10 WHO Regional Strategy on Sexual and Reproduc-
tive Health: Reproductive Health/Pregnancy Program 
(EUR/01/5022130). Copenhagen, Denmark, November 
2001.
11 Keesbury, Jill, et al. 2009. Mainstreaming Emergency Con-
traception in Kenya: Final Project Report. Nairobi: Popula-
tion Council, Nairobi and Population Services International, 
Kenya. 
12 Reproductive Health Supplies Coalition (August 2007): Moni-
toring and Evaluation Framework 2007–2015.
13 Central Bureau of Statistics (CBS) et al. 2004. Kenya Demo-
graphic and Health Survey 2003. Calverton, MD: CBS et al.
14  Population Services International–Kenya (PSI). 2009. Main-
streaming EmergencyContraception in Kenya: Final Narrative 
Report. Nairobi: PSI. 
15 Contraceptive Commodities for Women’s Health – UN Com-
mission. 2012. FP Synthesis_ Final 19 March.
16 Westley, Elizabeth and Eleanor Bimla Schwarz. 2012. 
“Emergency contraception: Global challenges, New 
opportunities” (editorial), Contraception 85: 429–431.
17 Op. cit. note 14.
18 Keesbury, Jill, et al. 2009. Mainstreaming Emergency Con-
traception in Kenya: Final Project Report. Nairobi: Popula-
tion Council, Nairobi and Population Services International, 
Kenya.
19 Obare, Francis, Jill Keesbury, and Wilson Liambila. 2010. 
“The provision of emergency contraceptives in private sector 
pharmacies in urban Kenya: Experiences of mystery clients.” 
African Population Studies 24(1–2).
20 Op. cit. note 11.
21 Republic of Kenya. 2012. National Family Planning Costed 
Implementation Plan (2012–2016), Ministry Of Health.
22 Republic of Kenya. 2007. MOH Printed Estimates and Vote-
Book. Nairobi: Republic of Kenya.
23 Powers, Shane. 2009. “The 5Ps of Marketing.” 
PowersBusiness.com.
24 International Consortium for Emergency Contraception 
(ICEC). 2013. “Introducing EC: A framework for designing 
an emergency contraception program” <http://cecinfo.org/
introducing-ec-a-framework/>. Accessed 1 February 2013.
25 Muia, E., et al. 2000. “What do family planning clients and 
university students in Nairobi, Kenya, know and think about 
emergency contraception?” African Journal of Reproductive 
Health 4(1): 77–87.
26 Republic of Kenya. 2012. National Family Planning 
Guidelines for Providers. Nairobi: DRH, MOPHS.

21
H.1 - Project Overview and Summary of Results
H.2 - Health Care Providers Quick Reference Guide
H.3 - Selling Protocol for Emergency Contraception Pills
H.4 - Job Aid for Bridging EC Users to Other RH Services
H.5 - Hormonal Emergency Contraception
H.6 - WHO Fact Sheet on Emergency Contraception
H.7 - MOH Monthly Supervision and Monitoring Tool
H.8 - Key M&E Indicators for FP commodities/EC Pills
SECTION H APPENDICES
PROJECT 
OVERVIEW AND 
SUMMARY OF 
RESULTS
H.1
23
Introduction
Emergency contraception (EC) is an important element of reproductive health care. EC is the only family planning method that can be used to prevent pregnancy after rape or unpro-tected sex. It does not cause abortion or harm to an existing pregnancy. 
According to the 2003 Kenya Demographic Health Survey 
(KDHS), close to half of the births in the preceding 5 years 
were mistimed or unwanted. The preliminary results of the 
2008 KDHS indicate that less than half (46%) of currently 
married women were using some method of contraception; 
use was lowest among women between the ages of 15 and 
24. Increased access to family planning, including EC, can 
reduce the number of unplanned pregnancies in the country 
and contribute to lower rates of abortion, child neglect, and 
abandonment. 
Despite increased media attention, EC remains a highly un-
derutilized method across Kenya. Recent data indicate that 
only 56% of women of reproductive age had ever heard of EC.1 To improve access to the method 
and ensure that adequate information is provided to all users, the Ministry of Public Health and 
Sanitation (MOPHS), the Population Council, and Population Services International- Kenya (PSI) 
undertook a three-year effort to mainstream EC in Kenya, which was supported by the William 
and Flora Hewlett Foundation. This brief presents the results of this initiative, and discusses strat-
egies for further strengthening EC provision in Kenya.
What Is EC?
“Emergency contraception” refers to the use of certain contraceptive 
methods by women and girls to prevent pregnancy after unprotected 
sexual intercourse. These methods include specific dedicated products 
(such as the brands Postinor 2 and Pregnon) and higher doses of other 
hormonal birth control pills (known as the Yuzpe method). EC is recom-
mended for women who have had unprotected sexual intercourse and 
desire to prevent pregnancy. In Kenya, dedicated EC pills (ECPs), are 
available in the public family planning clinics and as part of post-rape 
care services; they are also widely found in Kenya’s private sector phar-
macies and clinics. 
“I think we have not ad-
equately explained to the 
community that the morn-
ing-after pill should be used 
only in situations where 
people have accidentally 
had unprotected sex or in the 
case of sexual coercion.”
- Dr. Shahnaaz Sharif, Director, Pub-
lic Health and Sanitation, MOPHS
Mainstreaming Emergency  
Contraception Pills in Kenya
May 2010 Policy Brief
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The Kenyan National Family Planning Guidelines recommend use of 
ECPs within 120 hours for women who have had unprotected sexual 
intercourse and desire to prevent pregnancy.2 EC is the only contracep-
tive method that provides women with a second chance for preventing 
pregnancy after unprotected sex. ECPs do not cause abortion or harm an 
existing pregnancy, and are widely recognized as safe and easy to use. 
Any woman of reproductive age can use ECPs. While most women do not 
experience side effects, the most common side effects, including nausea, 
vomiting, and headaches, usually disappear within 24 hours. ECPs work 
by either inhibiting or delaying ovulation or preventing fertilization, de-
pending on the time it is taken during the cycle. Dedicated ECPs are effec-
tive in preventing up to 95% of pregnancies, and the Yuzpe method is effective in approximately 
75–80% of cases; the efficacy of ECPs is greater if taken as soon as possible after unprotected sex.
The initiative to mainstream ECPs in Kenya 
In 2006, the Population Council and PSI launched an initiative to support the MOPHS’ efforts 
to strengthen ECP provision in the public and private sectors. Activities included a national 
awareness-raising campaign, technical assistance to the Division of Reproductive Health (DRH) 
to build capacity and ensure supply sustainability, and efforts to improve ECP services in private 
sector pharmacies. 
Awareness-raising campaign: A national mass-media campaign, branded 
Tulia (“relax” in Kiswahili) was undertaken to increase public awareness 
of ECPs. It included national and local-language radio spots, informa-
tional articles in print media, expert interviews on radio and TV, and EC 
messages presented through popular local soap operas. PSI also devel-
oped brochures answering clients’ key questions and concerns regarding 
ECP use, which were distributed through pharmacies and private clinics. 
To encourage bridging clients from ECPs to regular family planning 
methods, PSI organized community-level events, such as discussion 
groups and career fairs, that provided women aged 18–30 with infor-
mation on ECPs and other regular family planning methods. All Tulia 
materials contained contact information for a youth reproductive health 
(RH) hotline run by Liverpool VCT, Care and Treatment. All hotline staff were trained to provide 
information and counseling to women with questions about EC. 
Public sector capacity-building: A study carried out by the Population 
Council in 2007 found that, while 96% of FP providers had heard of EC, 
only 56% had ever been trained to provide ECPs and far fewer demon-
strated adequate knowledge of the method. Guided by these findings, 
the DRH increased efforts to train FP providers on ECPs through contra-
ceptive technology updates. Partners from the USAID-funded national 
AIDS, Population and Health Integrated Assistance (APHIA II) Project, 
which reaches providers across the country, were also encouraged to em-
phasize the method in their trainings. Through these efforts, over 2,000 
providers received in-service training on ECPs between 2007 and 2008. A 
Visit the following websites for more information on EC:
ECafrique: The African Forum on Emergency Contraception; 	 www.ecafrique.org 
The International Consortium on Emergency Contraception; 	 www.emergencycontraception.org
Not-2-late.com 	 http://ec.princeton.edu/
The Latin American Consortium on Emergency Contraception (in Spanish); 	 www.clae.info
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quick reference guide and job aid were also developed for providers, and the 2010 revision of the 
National Family Planning Guidelines includes significantly strengthened guidance on ECPs. 
The government also took steps to strengthen pre-service training as a sustainable and cost-
effective approach to improving provider competence. With technical assistance from the Popula-
tion Council, the Nursing Council of Kenya revised its syllabus to include training on ECPs for 
student nurses. Efforts are currently underway to integrate EC into the Kenya Medical Training 
College’s curriculum. 
Supply sustainability: To improve recordkeeping and allow facilities to re-order ECPs, in 2008 the 
DRH added a column for ECPs to the revised FP register. The MOPHS also included purchase of 
ECPs in its budget, and in 2009, procured 5,875,000 ECPs with its own funding.
Strengthened pharmacy services: The Population Council worked in collaboration with the Pharma-
ceutical Society of Kenya to address concerns of private providers regarding EC provision, and 
test strategies for improving ECP services in the pharmacies. The Council conducted an interven-
tion study which worked to enhance the 
capacity of private pharmacy providers 
to provide quality ECP services. The 
study was conducted in 20 Nairobi phar-
macies and included three components: 
detailing providers on the appropriate 
use of ECPs and how best to dispense 
ECP to clients, ensuring the availability 
of Tulia brochures and posters in partici-
pating pharmacies, and providing “cheat 
sheets” containing five simple messages 
on ECPs to display at the counter. The in-
tervention also aimed to limit repeat use 
by “bridging” current users to other RH 
services, including VCT and longer-term
FP. 
Lessons learned on ECP provision in Kenya
The initiative has helped improve understanding of the dynamics of ECP provision in Kenya, 
increased access to the method in the public and private sectors, and developed innovative and 
cost-effective strategies for providing basic information to users. The key lessons learned are 
summarized below. 
Awareness and use of ECPs has increased dramatically in Kenya, but still remains low 
Awareness and reported use of ECP increased 
dramatically over the life of the initiative. In 
2003, the KDHS indicated that less than one 
quarter of Kenyan women had ever heard of 
ECPs.3 In 2007, PSI conducted baseline re-
search in 13 major towns and peri-urban areas 
across seven provinces, and found similar 
patterns, with only 21% of women reporting 
having ever heard of ECPs. Of those, only 15% 
could correctly identify ECPs as a contracep-
tive method taken after sex to prevent preg-
“Cheat” sheets with the key messages on EC (English and 
Kiswahili versions)
Table 1: Knowledge and use of EC in Kenya, DHS 
and PSI baseline surveys
* p=<0.05, comparing 2007 to 2009 results
Source Year
Ever heard of 
EC (women)
Ever 
use
DHS 2003 24% 0.9%
PSI baseline (n=675) 2007 24% 5% 
PSI endline (n=1252) 2009 56% * 10%*
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nancy.4 By 2009, 56% of women in the same sites had ever heard of ECP and 10% had ever used 
the method.5 
ECP sales data, obtained from the major ECP 
distributors in Kenya, also demonstrate an 
increased demand for the method. Figure 1 
charts the dramatic growth in ECP sales by dis-
tributors over a 22-month period. During that 
time, the number of ECP brands on the mar-
ket increased from 3 to 4, indicating a robust 
demand for the method. Similar trends are seen 
in the public sector, although the volumes are 
significantly lower.6 
However, PSI’s end line survey indicates that 
44% of all eligible women are still not aware 
that ECP exists, and misconceptions are rife 
among those who do know about the method. 
Of all women who know of ECPs, one-third be-
lieve that it causes abortion, and only about two-thirds know the correct timeframe for using the 
method. This indicates the need for continued education and awareness-creation on ECPs.
Private sector pharmacies dominate ECP provision in Kenya 
Data collected under the initiative demonstrate that private sector pharmacies are the most common 
access point for ECPs. PSI’s 2007 baseline survey found that 94% of women who had used ECP in 
the past two years obtained it from pharmacies.7 In 2009, their endline survey found that while 83% 
identified pharmacies as a place to obtain ECPs, only 25% mentioned government clinics.8
In 2008, as indicated in Figure 2, national-
level ECP distribution through private 
sector pharmacies was approximately twice 
that distributed through the public sector. 
Within government clinics, a 2007 record 
review found that 93% of the ECPs distrib-
uted in the previous 18 months were for 
sexual assault cases. While efforts under 
this initiative worked to strengthen ECP 
provision within FP and ARH services, it 
is likely that a bias toward sexual assault 
provision still exists within many public 
health facilities.9 
Qualitative research conducted with ECP users indicated that they preferred to access ECPs 
through pharmacies because it was convenient, quick and confidential.10 Two-thirds of women 
who purchased ECPs indicated that they had visited more than one pharmacy in an effort to 
maintain anonymity.11 
These findings suggest that the challenge in delivering quality ECP services within pharmacies 
lies with balancing efforts to provide basic information on the method without compromising 
the qualities that make pharmacies so attractive to clients. Within the public sector, the challenge 
rests with increasing the speed and confidentiality of ECP services within the context of larger FP 
programs. 
Figure 2: National sales of ECPs vs. public sector issues, 2008  
Figure 1: National sales of 4 ECP brands, over 
project life
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The majority of women who purchase ECPs from pharmacies are educated and employed 
Media reports have characterized ECP users, especially those who access EC from pharmacies, as 
“girls as young as 14.”12 Research conducted under this initiative, however, indicates that this is 
not the case. In 2007, the Population Council conducted a client intercept study (where clients are 
interviewed after receiving a service) with 147 women who bought ECPs at pharmacies in urban 
pharmacies located in five provinces (Nairobi, Coast, Rift Valley, Nyanza, and Western). 
The results show that the average age of women surveyed was 25 years, and the majority were 
between 20–29 years (72%). None of these women reported that they were aged 14 or below, and 
only 11% of respondents were between the ages of 15–19. Most clients had a college/university 
level of education (61%) and 61% were currently employed (including self-employment). About 
two-thirds (65%) were either married/cohabiting or single but in a steady relationship, but most 
women (57%) also reported engaging in sex on an infrequent or irregular basis. A significant pro-
portion (41%) reported having at least one child.13 
Some Kenyan women have used ECPs more than once in a month, but repeat users are less 
informed about the method
Respondents in the 2007 client intercept study were asked about the number of times they had 
used ECPs in the past six months, frequency of use in relation to sexual activity, and time since 
last purchase of ECPs. The categorization of “repeat use” is based on the last question, and is 
defined as a client who has bought ECPs at least once previously in the past one month.
Data indicate that a majority (58%) of women who had purchased ECPs had done so two or more 
times in the last month. Most of these purchasers (74%) stated that they used ECPs as their only 
method during their last act of sex, and nearly as many (70%) thought that ECPs were more con-
venient than other methods, while almost half preferred ECPs over methods such as daily contra-
ceptive pills or injectables. 
While repeat use of ECPs may be a conscious decision, it is not necessarily an informed one. The 
data also demonstrate that women who repeatedly used ECPs had greater misperceptions about 
the method’s mechanism of action and efficacy. Nearly 60 percent believed that ECPs are 100% ef-
fective, and many incorrectly believed that it would cause infertility or abortion. Overconfidence 
in ECP’s efficacy is likely to be one factor underpinning repeat use, with the benefits of conven-
ience in the short-term outweighing perceived long-term consequences.14
It is important to note that no significant negative health consequences have been associated with 
repeat use of ECP.15 Current national and international guidelines, however, do not encourage 
reliance on EC as a regular method of FP. According to the World Health Organization, recurrent 
use of EC indicates the need for further counseling on contraceptive options.16 No conclusive evi-
dence is available on the efficacy of ECPs if taken more than once in a cycle.
Pharmacies can provide better ECP services with minimal investment 
Given the key role pharmacies currently occupy in the provision of ECP in Kenya, and the dem-
onstrated need for better client counseling, innovative efforts are needed to improve EC services 
within pharmacies. 
The strategy for providing basic information to pharmacy clients tested under this initiative dem-
onstrated promising results. Results of this intervention indicated that, when given basic informa-
tion, pharmacy staff were more likely to provide basic information on ECPs (including when and 
how to use, mechanism of action, side effects, and efficacy) and discuss other FP and RH services 
with clients. These results suggest that sales staff at private sector pharmacies can deliver better 
ECP services, if given the proper tools. It also indicates that extensive, and often costly, training 
efforts are not needed to improve services within pharmacies.17
Figure 2: National sales of ECPs vs. public sector issues, 2008  
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Integrating skills and knowledge on ECPs into existing pre-service and in-service training 
programs can enhance public sector provision 
Under the initiative, efforts focused on integrating EC into existing pre- and in-service training 
programs in a cost-effective and sustainable manner. With minimal resources, modules on ECPs 
were inserted into ongoing trainings conducted by APHIA II partners and in the regular MOPHS 
Contraceptive Technology Updates (CTUs); evaluation data showed increased knowledge among 
trained providers. Perhaps the most strategic investment was in pre-service training, where lim-
ited technical and financial support enabled the integration of EC into the revised Nursing Coun-
cil’s curriculum, ensuring that all future nurses will receive instruction on ECPs. 
These experiences demonstrate that existing FP and RH initiatives can be successfully used to 
promote knowledge on ECPs. They also underscore the utility of integrating EC into existing 
activities, which is more-cost effective than stand-alone trainings and promotes the principle that 
EC should be addressed in the context of comprehensive FP and post-rape care services. 
Active advocacy is necessary to ensure adequate ECP stocks in the public sector. 
Supply sustainability of all contraceptives, especially ECPs, remains a major challenge for the 
Kenyan government. Continued or sustained stock-outs would undermine the gains made dur-
ing this initiative, and limit the impact of the policy and program changes that have been un-
dertaken in recent years. As knowledge of ECPs increase throughout the country, so will supply 
requirements, and efforts to ensure sufficient commodities should continue. 
Under the leadership of the DRH, advocacy efforts ensured that ECPs were included in the na-
tional contraceptive security plan and subsequent procurements. Since 2005, UNFPA has donated 
approximately 1,100,000 units to the MOPHS. In 2009, the MOPHS committed its own funds to 
purchase the country’s largest procurement of ECPs to date of 5,875,000 units. 
Recommendations 
The following recommendations are based on the lessons learned under this initiative.
Efforts to create public awareness and correct knowledge of ECPs should be continued.1.  While 
knowledge of ECPs is increasing in Kenya, many potential beneficiaries are still unaware of 
the method and many others are misinformed. Accurate public information and education is 
critical for encouraging correct use of ECPs. It is important, therefore, to include messages on 
ECPs in comprehensive FP communication campaigns. This can be achieved by integrating 
the existing Tulia materials and messages into the national RH communication strategy opera-
tional plan, and in the DRH’s community education and communication activities. The media 
can also play a critical role in creating correct public perceptions of the method, and should be 
regarded as a partner in these activities. 
Professional associations, including the Pharmaceutical Society of Kenya and the Kenya 2. 
Pharmaceutical Association, should continue educating their members on proper ECP provi-
sion. Given the central role pharmacies play in ECP access in Kenya, professional associations 
should work to confirm that their members are aware of strategies for ensuring clients are 
provided with the information they need to make informed decisions on ECP use. Such strat-
egies need not be costly or time-intensive; this initiative demonstrated one model for increas-
ing information provision in pharmacies, and others are likely to be feasible. At a minimum, 
the professional associations should include informational sessions and discussions on ECPs 
at all general meetings. 
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All MOPHS training partners should ensure that ECPs are integrated into all trainings on 3. 
FP, RH, adolescent health, or post-rape care. Numerous local and international NGOs assist 
the MOPHS with provider training. These partners’ contributions can also be used to increase 
knowledge on ECPs, with as little as two additional hours of instruction for trained health 
care providers. The DRH should integrate existing training materials and job aids into a 
standardized module on ECPs to ensure that all partners offer uniform, high-quality instruc-
tion. 
All pre-service training institutions and bodies should include ECP provision in their cur-4. 
ricula and examinations. Pre-service training is necessary to ensure that the next generation 
of Kenya’s health professionals are well equipped to provide this important and increasingly 
popular method. To do this, the country’s leading medical pre-service training institutions 
must revise their curricula to reflect the MOPHS’ renewed emphasis on quality ECP provi-
sion. 
The MOPHS, donors, and partners should continue to ensure that adequate ECP supplies are 5. 
available in the public sector. Adequate stocks are essential in ensuring the success of public 
sector ECP provision. Remarkable progress toward this has been achieved through the inclu-
sion of ECP in the government’s FP commodities procurement and security plans. It is recom-
mended that donors and other MOPHS partners continue to support the government to en-
sure that this emphasis on stock sustainability is maintained. Donors can also encourage their 
partners to integrate ECP issues in their reproductive health communications, service deliv-
ery, logistics, trainings, and research programs, and to explore innovative ways to strengthen 
private sector provision. 
Conclusion
Kenya has emerged as a leader in EC programming in the region. Through this initiative, it has 
demonstrated that it is possible to strengthen ECP services in both the public and private sectors 
while at the same time increasing public awareness, knowledge, and use of the method. 
The Kenyan experience can serve as a model for other countries on the continent interested in 
mainstreaming ECP services. While Kenya may have a longer history with the method than other 
African countries, ECPs are rapidly becoming widely available in African pharmacies due to the 
aggressive expansion of new products. Countries such as Uganda, Botswana, Ghana, Nigeria, 
Malawi, and Senegal are beginning to grapple with increased access in the private sectors, while 
many other governments are now more widely providing ECPs as a core element of post-rape 
care. The lessons learned from Kenya can serve as an invaluable resource to these countries.
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Introduction
According to the Kenya Demographic 
and Health Survey of 2003, close to 
half of the births in the preceding five 
years were mistimed or unwanted. 
Unplanned pregnancies lead women 
to seek abortions or have children 
they do not care for effectively. Use 
of emergency contraceptives (EC) is 
recommended for women who have 
had unprotected sexual intercourse and 
want to prevent pregnancy. The Minis-
try of Health recommends use of emer-
gency contraceptives (EC) within 120 
hours for women who have had unprotected sexual 
intercourse and want to prevent pregnancy. Effec-
tive provision of EC is an important component of 
adolescent reproductive health and post-rape care 
programs.
“I think we have not adequately explained to the 
community that the morning-after pill should be 
used only in situations where people have acciden-
tally had unprotected sex or in the case of sexual 
coercion.” (Dr. Shahnaaz Sharif, Head of Technical 
Services, Ministry of Public Health & Sanitation. 
Remarks made at the World Contraception Day 
event at Kangemi, Nairobi on 26 September 2008.)
“We need to educate members of the public so that 
they have the correct information regarding the use 
of the morning-after pill.” (Rosalyn Gichora, District 
Officer, Nairobi West District. Remarks made at 
the World Contraception Day event at Kangemi, 
Nairobi on 26 September 2008)
Why This Guide?
The Health Care Providers Quick Reference Guide 
has been developed as part of a larger ongoing 
program on mainstreaming EC in the public and 
private sectors. The main objective of this guide is 
to give an opportunity to health care providers to be 
able to make quick reference on any key issue with 
regard to EC in the course of their work. It is intend-
ed to supplement the information on EC provided 
in the current MOH Family Planning Guidelines for 
Service Providers.
What Is EC? 
Emergency contraception refers to the use of cer-
tain contraceptive methods by women and girls to 
Emergency Contraception 
Health Care Providers Quick Reference Guide
prevent pregnancy after unprotected 
sexual intercourse. These methods 
include specific products like Posti-
nor 2, and normal birth control pills. 
They should not be used as routine 
methods of family planning (FP). 
Why Is EC Important?
  EC provides a second chance for •	
preventing pregnancy after unpro-
tected sex.
  EC can reduce unwanted preg-•	
nancy which may result in child neglect, aban-
donment, and unsafe abortions. Unsafe abortion 
is a major cause of maternal death in Kenya.
EC is an important element in adolescent repro-•	
ductive health programs. Young people need to 
have correct information on many of the risk fac-
tors that are likely to negatively impact their lives 
such as sexually transmitted infections (STIs) 
HIV/AIDS and unintended pregnancies.
EC is important for post-rape care, prevention •	
of mother to child transmission of HIV, and is an 
essential component of quality FP service provi-
sion.
When Does a Woman Need to Use 
EC? 
EC is used after unprotected sex, including in the 
following situations: 
When no FP method is used.•	
When a method is used but it does not function •	
properl,y e.g., condom breaks, IUD slips out.
When a woman forgets to take oral contraceptive •	
pills for two or more days, or delays injectable for 
more than two weeks 
When a woman is raped/coerced into unprotected •	
sex.
Key Points about EC Pills
• Safe, effective, and easy to use. EC can be used 
safely by adolescents.
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• Should be started as soon as possible, but within 
120 hours of unprotected sex. The second pill 
should be taken within 12 hours after the first or 
alternatively the two pills can be taken at once (as 
a single dose).
• Referred to as “morning-after pill”, but this refer-
ence is misleading as it implies that one has to 
wait for some time before using the pill.
• No medical exam or pregnancy tests necessary.
• Can be used any time of the menstrual cycle.
• Should not be used as a regular method of con-
traception because EC pills are less effective and 
have more side effects than other family planning 
methods.
• EC pills do not work once a woman is pregnant. 
Therefore women/girls who are already pregnant 
should not take EC pills. However they will not 
harm a fetus that is already formed or cause a 
miscarriage.
• EC pills are available in MOH facilities and over 
the counter at pharmacies.
How Does EC Prevent Pregnancy?
EC pills work in various ways depending on the 
time in a woman’s cycle when she has sexual 
intercourse. EC does not cause abortion because it 
works before implantation.
EC Pills are thought to:
• Inhibit or delay ovulation.
• Inhibit/slow down transportation of egg/sperm 
through the fallopian tubes, hence preventing 
fertilization.
• Prevent implantation.
Types of Hormonal EC Pills/ 
Characteristics of EC Pills 
1. Dedicated EC pills contain the same progestin 
hormones as other progestin-only pills, although 
in higher doses. They are more effective than 
combined oral contraceptive pills and cause 
fewer side effects. This regimen prevents preg-
nancy by about 85% if taken within 120 hours.
• There are many brands of dedicated EC pills 
currently available in Kenya, such as Postinor 
2, Pregnon, Smart Lady, ECee2, and Truston2.
• Some of these brands are found in government 
health facilities and should be ordered in the 
same way as other contraceptives.
2. Combined oral contraceptive pills, also called 
Yuzpe method, contain the hormones estrogen 
and progestin and prevent about 75% of expect-
ed pregnancies.
3. Progestin-only contraceptive pills can be used for 
EC. One needs two doses of 20 tablets.
The following are dosage guidelines 
for different EC pills regimens
Pill type
Common 
brand 
names
Tablets 
per 
dose Doses
Timing of  
administration
Dedicated EC pill- 
LNG ECP package 
with single dosage 
pill of 1.5mg of 
levonorgestrel **
Postinor 2
Pregnon
Smart lady
Ecee2
1
1
1
1
1
1
1
Dose to be 
taken within 
120 hours after 
unprotected 
sex.
Dedicated EC pills- 
LNG ECP package 
containing two pills 
of 0.75 mg of lev-
onorgestrel each**
Postinor 2
Pregnon
Smart lady
Ecee2
2
2
2
2
1
1
1
1
Dose to be 
taken within 
120 hours after 
unprotected 
sex.
50 mcg estrogen 
pills
Eugynon 2 2 First dose to be 
taken within 120 
hours after un-
protected sex. 
Second dose 12 
hours later.
30 mcg estrogen 
pills
Micro-
gynon
4 2
Progestin only pills Microlut 20 2
Side Effects and Management
• Nausea and vomiting are the most common side 
effects.
• Other possible effects include headaches, dizzi-
ness, fatigue, and breast tenderness due to the 
high hormone doses in emergency contraception 
pills.
• Most side effects generally disappear within 24 
hours of taking the pills.
• To reduce the effects of nausea, EC pills can be 
taken with food or a medical provider can offer 
anti-nausea drugs before taking EC.
• If a woman vomits <2 hours after taking a dose of 
EC the dose should be repeated.
• If vomiting occurs more than 2 hours after taking 
ECPs, she does not need to take any extra pills.
**1.5 mg of levonorgestrel or two 0.75 mg of levonorgestrel pills taken at once 
in a single dose improves compliance (1.Dada OA, Godfrey EM, Piaggio G, von 
Hertzen H. “A randomized, double-blind, noninferiority study to compare two 
regimens of levonorgestrel for emergency contraception in Nigeria.” Contraception 
2010; 82(4): 373-8. 2. Piaggio G, Kapp N, von Hertzen H. “Effect on pregnancy 
rates of the delay in the administration of levonorgestrel for emergency contracep-
tion: a combined analysis of four WHO trials.” Contraception 2011; 84 (1): 35-9).
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Counseling Clients
Women needing EC may be in crisis and fear 
unplanned pregnancy. As much as possible it is 
important for a provider to counsel a client on EC. 
Unless in the case of rape, it is an opportunity to 
discuss use of regular FP method.
• Recommend that the client use a method of FP 
for the rest of the cycle after taking EC pills.
• Many women who need EC also need protection 
from STIs/HIV. Counseling on EC is an opportu-
nity to discuss the risks of STIs and prevention 
options.
•  When you explain mode of action to clients, reas-
sure them that EC pills do not cause abortion.
•  Discuss the possibility that EC may fail.
• Refer clients for FP and other reproductive health 
services. Women who have been raped or trau-
matized need to be referred for more comprehen-
sive medical and psychosocial care.
Starting Family Planning Methods 
after EC
Method When to start
Condom Immediately after ECUse also for dual protection
Oral contraceptive pills Next day after 2nd dose of EC or 1–7 days after menses
Injection
IUD
Norplant
1–7 days after next period
EC pills and HIV/AIDs/STIs
EC pills do not protect against STIs including HIV.
• All EC users should also be referred for voluntary 
counseling and testing.
• In case of rape, providers can give post-exposure 
prophylaxis for STIs/HIV.
Common questions
• What are the effects of EC on periods?
 EC pills do not cause periods to start immediately. 
Periods will come at the normal time but may be 
delayed or come early by 2–3 days.
• Can EC pills protect one for the rest of the cycle?
 It will not, and any further unprotected acts put 
one at risk. Women should use a regular method 
of FP or condoms for further protection.
• Can EC pills harm an already formed baby?
 No. It has been determined that EC pills do not 
have any serious harmful effects ona formed 
baby.
• When can one resume/start a regular FP method 
after taking EC?
 One can start by using condoms and pills. One 
has to wait until the next period to begin using 
injections, IUDs and implants.
• Can I use EC pills every time I have sex?
 Women/girls should not use EC pills as a regular 
method. They should only be used in emergency 
situations. EC pills are less effective than many 
regular FP methods.
• What if I have unprotected sex again after taking 
EC?
 If one has unprotected sex after using EC, it will 
not offer protection from pregnancy. One will need 
to repeat the treatment, unless already using a 
regular FP method.
• What if I had sex multiple times before taking EC 
pills?
 You can still use EC pills if the last time you had 
sex was within five days. If one is already preg-
nant from an earlier act of unprotected sex, the 
EC pills will not have any effect.
This booklet has been adapted from the National FP Guidelines (Kenya MOH, 2005), with additional 
information drawn from Family Planning: A Global Handbook for Providers (WHO: Geneva, 2008). The 
adaptation was conducted by the staff of the Division of Reproductive Health, Ministry of Public Health and 
Sanitation and ECafrique staff of the Population Council. Publication date 2008. 
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Below is a recommended emergency contracep-
tive pills (ECPs) selling protocol that the Population 
Council in collaboration with other professionals 
proposes can be used in dispensing the emergency 
pills.
1.  Assess the risk of pregnancy: 
In case of missed pills•	 : Advise the patient to 
carry on with the next pill as normal. If they had 
unprotected sex, then emergency contracep-
tive pills are indicated. Inform the patient that 
they will not be covered by the contraceptive 
and that a barrier form of contraception such 
as a condom should be used for a further 10 
days or until the end of the cycle. They can 
have their normal break and carry on with the 
regular contraception as normal.
In case of a broken, slipped condom•	 , the emer-
gency contraceptive pills (ECPs) are indicated 
and should be administered as soon as pos-
sible. 
In case of unprotected sex including both con-•	
sensual and nonconsensual sex: EC pills are 
indicated and should be administered as soon 
as possible.
2.  Establish if the client is taking any other  
medication.
Many enzyme-inducing drugs reduce the effec-
tiveness of emergency pills. Drugs to watch out 
for are anticonvulsants such as carbamezapine, 
and phenytoin; anti-HIV drugs such as ritonavir; 
anti-TB drugs such as Rifampicin and Rifambu-
tin; herbal drugs; cyclosporin; and antibiotics.
3.  Establish if the client has any stomach condi-
tion such as Crohn’s or severe liver disease. 
These can reduce the absorption and metabo-
lism of ECPs.
4. Ensure that the client is within the 120-hour 
period. 
5.  Give advice: 
EC Pills: two tablets can be taken at the a. 
SAME time, avoiding the need to wait for 12 
hours, with the same efficacy.
Take the pills as soon as possible.b. 
The pills may induce nausea; however, if the c. 
client vomits within three hours of taking the 
pill, she should return and purchase another 
dose as the first dose may not work.
Side effects are rare and transient. Side ef-d. 
fects may be headaches, dizziness, breast 
tenderness, nausea, and vomiting. If the 
client is concerned, she should speak to her 
doctor; however, after years of research on 
this drug, there is no evidence of any long-
acting adverse effects.
Advise the client that her next period may be e. 
heavy or light, early or late. If it is more than 
five days late she should seek medical advice 
and get herself tested for pregnancy.
Advise clients on the use of regular contra-f. 
ception and risks of STIs.
6. EC reference materials should be given out. 
These include the EC Quick Reference Guide 
and the 2010 edition of the National Family 
Planning Guidelines by the Division of Repro-
ductive Health (DRH) of Kenya’s Ministries of 
Health for providers; and guides such as the 
Tulia patient information brochure developed by 
MOHs and partners for patients. The patient in-
formation guides should be given out to comple-
ment the advice given.
7.  Communication: Communicate with empathy, 
discretion, and in a nonjudgmental way. Ask 
open questions and double-check the patient’s 
understanding. If you can, have a quiet area in 
your pharmacy where private discussions can 
be held. 
Some pharmacists and health care professionals 
have expressed concerns that women might “abuse” 
emergency contraception pills by using them repeat-
edly or using them instead of regular contraception. 
The main point to bear in mind here is that from a 
safety point of view, no serious side effects have been 
reported from repeated use of levonorgestrel ECPs, 
usually a change in the menstrual cycle is seen. If ad-
vice is given on regular contraception and the risk of 
STIs including HIV/AIDS at the point of supply of ECPs, 
then pharmacists will also be playing a major role in 
the effective use of emergency contraception and 
family planning in general. It is in the pharmacists’ 
hands to uplift the profession. The sale and supply of 
ECPs enables pharmacists to play a more active role 
in improving the sexual health of the nation. 
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Source: MOH-Kenya. 2010. National Family Planning Guidelines for Services Providers.
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HoRMoNAl EMERGENCy CoNTRACEPTIoN: WHAT IS IT?
Emergency contraception refers to the use of certain contraceptive methods by women in the reproduc-
tive age group to prevent pregnancy after unprotected sexual intercourse. Hormonal emergency contra-
ceptive pills (ECPs) must be taken within 120 hours of intercourse, however, the sooner they are taken, 
the more effective they are. EC provides a second chance for preventing pregnancy after unprotected 
sex, either accidental or following coerced sex/rape. 
It should be emphasised that emergency contraception should not be used on a regular basis 
(from month to month) because it is less effective than other methods.
Depending on the regimen used and number of hours passed since unprotected intercourse, emer-
gency contraceptive pills seem to prevent between 75% and 95% of pregnancies that would otherwise 
have occurred. The average chance of pregnancy resulting from one act of unprotected intercourse in 
the second or third week of the menstrual cycle is estimated at 8%; after emergency oral contraception 
it is 1–2%. The sooner after unprotected intercourse ECPs are used, the more effective they are in pre-
venting pregnancy. Also a progestin-only regimen is more effective than a combined oral contraceptives 
regimen.
Emergency contraception pills work in various ways to prevent pregnancy. This depends on the time in 
a woman’s cycle when she has sexual intercourse. EC does not cause abortion because it works before 
implantation. Thus EC pills prevent pregnancy by:
Preventing or delaying ovulation; and•	
Inhibiting or slowing down transportation of the egg and/or sperm through the fallopian tubes; •	
hence preventing fertilization and implantation.
TyPES oF HoRMoNAl EC PIllS AND DoSAGE 
Combined Oral Contraceptives (COC) (also called Yuzpe method). 
These contain the hormones estrogen and progestin and prevent about 75% of the expected pregnan-
cies.
50 mcg estrogen pills (e.g. , Eugynon): Two tablets to be taken as soon as possible, but within 
120 hours of unprotected intercourse. Repeat same dose in 12 hours. A total of 4 pills are re-
quired.
Or
30 mcg estrogen pills (e.g., Microgynon): Four tablets to be taken as soon as possible, but 
within 120 hours of unprotected intercourse. Repeat same dose in 12 hours. A total of 8 pills are 
required.
Progestin-only Oral Contraceptives
Dedicated emergency contraceptive (levonogestrel) pills:
These contain the same progestin hormones as other progestin-only pills, although in higher doses. 
They are more effective than combined pills. Examples of brands of dedicated EC pills available in 
Kenya are: Postinor 2, Pregnon, Smart lady, ECee2, and Truston2, among others. 
One 750 mcg levonorgestrel pill to be taken as soon as possible, but within 120 hours of un-
protected intercourse. Repeat same dose in 12 hours. A total of 2 pills are required.
Or 
Two 750 mcg levonorgestrel pills to be taken as a single dose as soon as possible, but within 
120 hours of unprotected intercourse. This regimen is preferred because the issue of compli-
ance with treatment does not arise.
Or
Regular progestin-only pill (POP) may be used: 20 tablets taken within 120 hours of unpro-
tected intercourse. Repeat same dose in 12 hours. A total of 40 pills are required.
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Dosage guidelines for different EC regimens
PIll TyPE
CoMMoN
bRANDS
TAblETS 
PER DoSE DoSES
ToTAl 
DoSES
TIMEFRAME FoR  
ADMINISTRATIoN oF DoSAGE
a) Combined oral contraceptive pills:
50 mcg estrogen pills Eugynon 2 2 4 First dose within 120 hrs; 2nd 
dose 12 hrs later30 mcg estrogen pills Microgynon 4 4 8
b) Progestin-only dedicated EC Pills:
750 mcg levonorg-
estrel pill
Postinor 2,
Pregnon,
Smart lady,
Ecee2,
Truston2
1
1
1
1
1
2
2
2
2
2
2 First dose within 120 hrs after 
unprotected sex; 2nd dose 12 
hrs later
1.5 mg (1500mcg) 
levonorgestrel pill*
Postinor 2,
Pregnon,
Smart lady,
Ecee2, 
Truston2
2
2
2
2
2
1
1
1
1
1
2 Single dose within 120 hrs 
after unprotected sex.
c) Regular progestin only pill (POP) 
Regular progestin-
only pill (PoP) 
Microlut 20 2 40 First dose within 120 hrs after 
unprotected sex; 2nd dose 12 
hrs later
  * This regimen is preferred since it improves compliance (WHO 2008: Global Handbook for Providers on FP and 
Emergency Contraception- Health Care Providers Quick reference Guide(MOPHS, DRH 2008).
ADVANTAGES 
Provides emergency protection (prevents pregnancy) in about 75% to 95% of those at risk. • 
EC can reduce unwanted pregnancy which may result in child neglect, abandonment, or unsafe • 
abortions which are a major cause of maternal death in Kenya. 
Is an important element in post-rape care, prevention of mother-to-child transmission of HIV and is • 
an essential component of quality family planning service provision. 
Safe, effective, and easy to use. • 
No medical examination or pregnancy tests are necessary or required.• 
Can be used any time during the menstrual cycle.• 
Emergency contraception pills are available in the government, private, and NGO health facilities • 
and over the counter at pharmacies. 
lIMITATIoNS 
Only effective within 120 hours of unprotected intercourse. • 
Not to be used as a regular method.• 
Does not protect against STls/HIV/AIDS.• 
May cause nausea (more common for COC regimen).• 
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WHo CAN USE EMERGENCy CoNTRACEPTIoN ?
Emergency oral contraception should not be used in place of regular family planning methods. It 
should be emphasised that EC contains a much higher dose of the hormones compared to the regular 
hormonal contraceptive methods. Therefore, it should be used only in an emergency, for example:
Sex took place without contraception, and the woman wants to avoid pregnancy.  • 
A woman has run out of oral contraceptives, has missed 2 or more POPs, or is more than 4 weeks • 
late for her DMPA injection and has had unprotected intercourse.
A woman has had coerced sexual intercourse, such as rape.• 
A condom has broken.• 
An IUD has come out of place.• 
Proceed with care in the following situations
CoNDITIoN SUGGESTED ACTIoN
Women with history of severe  
cardiovascular complications (e.g.,  
IHD, CVA or other thromboembolic  
conditions)
Should be given the regimen without the delay; they may 
need follow-up after they have taken the pills. 
Any delay may take them to the point beyond 120 hours 
when ECPs are not effective anymore, 
Pregnancy poses much more risk for these women than 
ECPs do.
The duration of use of EC is less than that of regular use of 
COCs or POPs and thus would be expected to have less 
clinical impact.
Woman with angina pectoris
Women suffering from migraine
Women with severe liver disease  
(including jaundice)
WHo SHoUlD NoT USE 
EC is not to be used as a regular method. Recurrent demand for EC is an indication that the woman 
requires further counseling on other contraceptive options. 
Frequently repeated EC use may be harmful for women with conditions classified as “Use with care” 
(category 2) and “Who should not use” (categories 3 and 4) for hormonal methods. 
EC should not be given to women who are known to be pregnant. 
The success of emergency contraception depends on awareness and knowledge of its avail-
ability/efficacy prior to an unprotected, unplanned act. The method is only effective if potential 
users are aware of the method by prior information and counseling.
KEy PoINTS FoR PRoVIDERS AND ClIENTS
EC pills should be started as soon as possible, but within 120 hours of unprotected sex•  
EC is referred to as the “morning-after pill,” but this reference is misleading as it implies that one • 
has to wait for sometime before using the pill.
Emergency contraception pills do not work once a woman is pregnant. Therefore women/girls who • 
are already pregnant should not take emergency contraception pills. 
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Management of common side effects 
 SIDE EFFECTS MANAGEMENT
Nausea and vomiting 
(more common with 
COC regimen)
Women should be counseled of the possible occurrence of nausea at the 
time of ECP supply. For women using a combined pill or POP for ECP, where 
possible, an anti-emetic may be used before the pills are taken. 
If vomiting occurs within 2 hours, repeat the previous ECP dose orally as 
soon as possible.
If a woman again vomits, give the dose vaginally (place the needed dose 
high up in the vagina)
Slight irregular bleeding Reassure that this is not a sign of pregnancy or other condition.
Irregular bleeding due to ECPs is common and will stop without treatment.
Change in timing of next 
monthly bleeding
Explain that it is not unusual for the next monthly bleeding to start a few days 
earlier or later than expected.
Assess for pregnancy if woman’s next monthly bleeding is more than one 
week later than expected.
WHo CAN PRoVIDE EC?
Clinical Providers
Medical Doctors • 
Nurses/Midwives• 
Clinical officers• 
Non-clinical providers
Trained Pharmacists/Pharmaceutical Technologists • 
Trained Community Health Extension Workers (CHEWs)- Nurse/midwives, Public Health Officers • 
(PHO), Public Health Technicians (PHT)
Trained Community Health Workers (CHWs) including Community–based Distributors (CBDs)• 
other Providers
All trained providers including CBDs, pharmacy assistants, community health workers, trained • 
peer counselors.1
WHERE EC CAN bE PRoVIDED 
All service delivery points:
Level 4 and above (hospitals)• 
Level 3 (health Centers, nursing/maternity homes)• 
Level 2 (dispensaries, HTC centers, private clinics)• 
Level 1 (outreach, including CHWs, CBDs, and mobile services), pharmacies/ chemists, SGBV • 
centers) and any site with a trained provider (home, shop). 
1  World Health Organisation (2012), WHO recommendations. Optimizing health worker roles to improve access to key maternal and new-
born health interventions through task shifting.
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STARTING FAMIly PlANNING METHoDS AFTER EC
METHoD WHEN To START
Condom Immediately after EC use also for dual protection
Oral contraceptive pills Next day after 2nd dose of EC or 1–7 days after menses
Injection 1–7 days after next period
IUD
Norplant
Permanent method
Natural method
bRIDGING EC USERS To oTHER REPRoDUCTIVE HEAlTH SERVICES 
EC providers are expected to explain the mode of action of EC to the client including the fact that EC is 
not 100% effective at reducing the risk of pregnancy. Except in the case of rape, providers are expected 
to discuss the use of a regular FP method and emphasize that EC pills are for emergency use only. All 
providers are supposed to inform users of all FP methods available and that the FP methods (except 
condoms) do not protect women against sexually transmitted infections (STIs) including HIV/AIDS. 
Many women who need EC also need protection from STIs/HIV and therefore counseling on EC is an 
opportunity to discuss the risks and prevention options for STIs/HIV/AIDS including the need for coun-
seling and testing services. Refer clients for FP and other RH services. Women who have been raped 
or traumatized also need to be referred for more comprehensive medical and psychosocial care.
Common Questions
What are the effects of EC on periods•	 ? EC pills do not cause periods to start immediately. 
They will come at the normal time but may delay or come early by 2–3 days
Can EC pills protect one for the rest of the cycle•	 ? They will not, and any further unprotected 
acts put one at risk. Women should use a regular method of FP or condoms for further protec-
tion.
When can I resume/start a regular FP method after taking EC? •	 One can start by using con-
doms and pills. One has to wait until next period to begin using injections, IUDs, and implants.
Can I use EC pills every time I have sex?  •	 Women/girls should not use EC pills as a regular 
method. They should only be used in emergency situations. EC pills are less effective than many 
regular FP methods
What if I had sex multiple times before taking EC pills? •	 You can still use EC pills if the last 
time you had sex was within 5 days. If one is already pregnant from an earlier act of unprotected 
sex, the EC pills will not have any effect.
Source: MOH-Kenya. 2010. National Family Planning Guidelines for Services Providers.
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Key facts
Emergency	contraception	can	prevent	most	pregnancies	when	taken	after	intercourse.	•	
Emergency	contraception	can	be	used	following	unprotected	intercourse,	contraceptive	failure,	incorrect	•	
use	of	contraceptives,	or	in	cases	of	sexual	assault.	
There	are	two	methods	of	emergency	contraception:	emergency	contraceptive	pills	(ECPs)	and	copper-•	
bearing	intrauterine	devices	(IUDs).	
When	inserted	within	five	days	of	unprotected	intercourse,	a	copper-bearing	IUD	is	the	most	effective	•	
form	of	emergency	contraception	available.	
The	emergency	contraceptive	pill	regimen	recommended	by	WHO	is	one	dose	of	levonorgestrel	1.5	mg,	•	
taken	within	five	days	(120	hours)	of	unprotected	intercourse.
Emergency	contraception,	or	post-coital	contraception,	refers	to	methods	of	contraception	that	can	be	
used	to	prevent	pregnancy	in	the	first	few	days	after	intercourse.	It	is	intended	for	emergency	use	following	
unprotected	intercourse,	contraceptive	failure	or	misuse	(such	as	forgotten	pills	or	torn	condoms),	rape	or	
coerced	sex.	
Emergency	contraception	is	effective	only	in	the	first	few	days	following	intercourse	before	the	ovum	is	
released	from	the	ovary	and	before	the	sperm	fertilizes	the	ovum.	Emergency	contraceptive	pills	cannot	
interrupt	an	established	pregnancy	or	harm	a	developing	embryo.
Who needs emergency contraception?
Any	woman	of	reproductive	age	may	need	emergency	contraception	at	some	point	to	avoid	an	unwanted	
pregnancy.
In what situations should emergency contraception be used?
Emergency	contraception	can	be	used	in	a	number	of	situations	following	sexual	intercourse:
When	no	contraceptive	has	been	used.	•	
When	there	is	a	contraceptive	failure	or	incorrect	use,	including:	•	
condom	breakage,	slippage,	or	incorrect	use;	•	
three	or	more	consecutively	missed	combined	oral	contraceptive	pills;	•	
the	progestogen-only	pill	(minipill)	taken	more	than	three	hours	late	(or	more	than	12	hours	late	if	tak-•	
ing	a	0.75	mg	desogestrel-containing	pill);	
norethisterone	enanthate	(NET-EN)	progestogen-only	injection	taken	more	than	two	weeks	late;	•	
depot-medroxyprogesterone	acetate	(DMPA)	progestogen-only	injection	taken	more	than	four	weeks	•	
late;	
the	combined	estrogen-plus-progestogen	monthly	injection	taken	more	than	seven	days	late;	•	
dislodgment,	delay	in	placing,	or	early	removal	of	a	contraceptive	hormonal	ring	or	skin	patch;	•	
dislodgment,	breakage,	tearing,	or	early	removal	of	a	diaphragm	or	cervical	cap;	•	
failed	withdrawal	(e.g.,	ejaculation	in	the	vagina	or	on	external	genitalia);	•	
failure	of	a	spermicide	tablet	or	film	to	melt	before	intercourse;	•	
miscalculation	of	the	periodic	abstinence	method,	or	failure	to	abstain	or	use	a	barrier	method	on	the	•	
fertile	days	of	the	cycle;	
expulsion	of	an	intrauterine	contraceptive	device	(IUD)	or	hormonal	contraceptive	implant.	•	
In	cases	of	sexual	assault	when	the	woman	was	not	protected	by	an	effective	contraceptive	method.	•	
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Methods of emergency contraception
There	are	two	methods	of	emergency	contraception:
emergency	contraception	pills	(ECPs)	1.	
copper-bearing	intrauterine	devices	(IUDs).2.	
1. Emergency contraception pills
WHO	recommends	levonorgestrel	for	emergency	contraceptive	pill	use.	Ideally,	this	progestogen-only	
method	should	be	taken	as	a	single	dose	(1.5	mg)	within	five	days	(120	hours)	of	unprotected	intercourse.	
Alternatively,	a	woman	can	take	the	levonorgestrel	in	two	doses	(0.75	mg	each;	12	hours	apart).	
Mode of action 
Levonorgestrel	emergency	contraceptive	pills	prevent	pregnancy	by	preventing	or	delaying	ovulation.	They	
may	also	work	to	prevent	fertilization	of	an	egg	by	affecting	the	cervical	mucus	or	the	ability	of	sperm	to	
bind	to	the	egg.
Levonorgestrel	emergency	contraceptive	pills	are	not	effective	once	the	process	of	implantation	has	begun,	
and	they	will	not	cause	abortion.
Effectiveness 
Based	on	reports	from	nine	studies	including	10,500	women,	the	WHO-recommended	levonorgestrel	regi-
men	is	52–94%	effective	in	preventing	pregnancy.	The	regimen	is	more	effective	the	sooner	after	inter-
course	it	is	taken.
Safety 
Levonorgestrel-alone	emergency	contraception	pills	are	very	safe	and	do	not	cause	abortion	or	harm	future	
fertility.	Side	effects	are	uncommon	and	generally	mild.
Medical eligibility criteria and contraindications 
Emergency	contraceptive	pills	prevent	pregnancy.	They	should	not	be	given	to	a	woman	who	already	has	
a	confirmed	pregnancy.	However,	if	a	woman	inadvertently	takes	the	pills	after	she	becomes	pregnant,	the	
available	evidence	suggests	that	the	pills	will	not	harm	either	the	mother	or	her	fetus.	
Emergency	contraceptive	pills	are	for	emergency	use	only	and	are	not	appropriate	for	regular	use	as	an	
ongoing	contraceptive	method	because	of	the	higher	possibility	of	failure	compared	with	non-emergency	
contraceptives.	In	addition,	frequent	use	of	emergency	contraception	can	result	in	side	effects	such	as	
menstrual	irregularities,	although	their	repeated	use	poses	no	known	health	risks.
There	are	no	medical	contraindications	to	the	use	of	levonorgestrel	emergency	contraception	pills.	
2. Copper-bearing intrauterine devices (IUDs)
WHO	recommends	that	a	copper-bearing	IUD,	as	an	emergency	contraceptive,	be	inserted	within	five	days	
of	unprotected	intercourse.	This	may	be	an	ideal	emergency	contraceptive	for	a	woman	who	is	hoping	for	
an	ongoing,	highly	effective	contraceptive	method.	
Mode of action
As	emergency	contraception,	the	copper-bearing	IUD	primarily	prevents	fertilization	by	causing	a	chemical	
change	that	damages	sperm	and	egg	before	they	can	meet.	
Effectiveness
When	inserted	within	five	days	of	unprotected	intercourse,	a	copper-bearing	IUD	is	over	99%	effective	in	
preventing	pregnancy.	This	is	the	most	effective	form	of	emergency	contraception	available.	Once	inserted,	
the	woman	can	continue	to	use	the	IUD	as	an	ongoing	method	of	contraception,	and	she	may	choose	to	
change	to	another	contraceptive	method	in	the	future.	
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Safety
A	copper-bearing	IUD	is	a	very	safe	form	of	emergency	contraception.	The	risks	of	infection,	expulsion	or	
perforation	are	low.	
Medical eligibility criteria and contraindications
The	only	situation	in	which	a	copper-bearing	IUD	should	never	be	used	as	emergency	contraception	is	if	
a	woman	is	already	pregnant.	There	are	other	contraindications	to	using	a	copper-bearing	IUD	as	ongo-
ing	contraception,	which	also	should	be	considered	before	its	use	as	emergency	contraception.	For	more	
information,	please	refer	to	the	WHO Medical Eligibility Criteria for Contraceptive Use.
WHO response
WHO’s	activities	on	emergency	contraception	form	part	of	its	work	to	provide	access	to	high-quality	serv-
ices	for	family	planning,	particularly	for	the	most	vulnerable	populations.	This	work	is	shaped	by	the	WHO	
Global	Reproductive	Health	Strategy.
In	addition,	through	the	UNDP/UNFPA/WHO/World	Bank	Special	Program	of	Research,	Development	and	
Research	Training	in	Human	Reproduction	(HRP),	research	is	carried	out	that	aims	to	provide	the	wid-
est	range	of	safe	and	effective	family	planning	methods,	as	well	as	clinical	research	into	novel	methods	or	
uses.
WHO	reaffirms	its	commitment	to	keeping	emerging	evidence	under	close	review	through	its	Continuous	
Identification	of	Research	Evidence	(CIRE)	system.	
For more information contact:
WHO	Media	centre		
Telephone:	+41	22	791	2222		
E-mail:	mediainquiries@who.int	
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(For use by provincial/regional, district/county/local authorities and officers in charge of health facilities.) 
Objectives of Supervision and Monitoring Visits:
To increase the knowledge and strengthen the skills of health providers to effectively manage •	
the logistics system for FP including EC .
To identify performance weaknesses, and improve performance through on job training as •	
needed.
To ensure that established logistics guidelines and procedures regarding FP/EC commodities •	
are being followed. 
To estimate the required quantities of FP commodities including EC per . that are ordered or •	
issued
To assess whether clients are getting the services they want when they need them•	
To verify that all records are correctly maintained and reports are submitted on time.•	
To determine the quantity of supplies to order or issue•	
To discuss the way forward with the local health management teams with a view to increasing •	
access to FP/ECPs in the community and clients seeking these services
1. Health Facility Characteristics
Name of facility and postal address…….…………………………………………a) 
Type of Facility (Circle appropriate code: Hospital = 1; Health center = 2; Dispensary = 3;)b) 
Managing authority (Circle appropriate code: Government=1; Faith-based = 2; NGO=3; c) 
Private = 4; Other=5) 
District/County/Local authority…….…………………………………………d) 
Province/Region…….…………………………………………e) 
Date of visit f) …….……………
Person interviewed g) …….……………………………………
2. Personnel Characteristics
Indicate the number of staff working at the facility who are trained in FP including EC 
 No. of staff working in the facility trained in FP including EC in the 
past 1-3 years (in service)
Cadre Total no. in 
the facility
No. trained in FP & 
EC (in service)
No. trained in other RH services e.g., STIs/ 
HIV, gender issues, safe motherhood, etc.
Medical officers
Clinical officers
Nurses
Pharmacy staff
Others (specify)
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3. FP/EC Staff Training
Are there regular continuing medical education /OJT programs in the district(s)/facilities on a) 
FP/EC activities?
How do you ensure that as many staff as possible in the district(s)/facilities have access to b) 
these updates? 
4.  Availability of FP/EC Tools in the Facility
Are the following tools available and in use in the facility?
Tools available
Yes in use
Place tick √
Not in use
Place tick √
Explanation if tool (s) 
not in use 
FP register with EC column
District monthly contraceptives request and 
reporting form
Facility monthly contraceptives request and 
reporting form
Job aids (F/EC) 
Other (specify)
5. Are the Following Materials Present in the Health Care Provider’s Room?
Materials available
Yes in use
Place tick √
Not in use
Place tick √
Explanation if tool(s) not in use 
National FP Guidelines
Post-rape/SGBV guidelines
FP job aids inclusive of EC ones
EC counseling job aid
Others (specify)
6. Status of Commodities During the Month
Did the facility experience stock outs of the following commodities for more than 7 days last 
month? (Place a tick in the appropriate “yes” or “no” column for each of the items listed). If FP 
commodities were not available, discuss with the facility staff and outline the reasons in the ap-
propriate row in the table.
Commodity stock outs for more than 7 days y N Reasons for stock outs (if response was “y”)
a) Combined oral pill (COP)
b) Emergency contraceptive pills
c) IUD
d) Depo Provera
e) Implants (e.g., Jadelle, Implanon,  
Sino-implant)
f) Male condoms 
g) Female condoms
h) Microlut
i) Others (specify)
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7. ECP Provision to Clients
 Which cadres of health care providers prescribe ECPs to the clients?i) 
 In which areas of the facility can EC services be accessed by the clients? ii) 
 Are the EC services and commodities accessible at night and in the weekends?iii)
  What EC regimes are used?iv) 
Dedicated pill•	
“Yuzpe” regimen•	
Find out from the district/health facility the most common indication (s) for ECPs in their v) 
respective areas/region(s): 
Rape•	
FP method failure•	
Just had unprotected sex•	
Others (specify_________________________)•	
8. Service Statistics 
Check for the number of clients who received FP and EC services from the facility/district or 
county in the last completed quarter. 
9. Comments/remarks
a) Outline some of the achievements, program strengths and available opportunities for strengthening 
integration activities for RTIs/STIs/HIV within reproductive health settings in the facility, etc.
______________________________________________________________________________________
______________________________________________________________________________________
______________________________________________________________________________________
b) Outline some of the key challenges, and constraints experienced during the month.
______________________________________________________________________________________
______________________________________________________________________________________
______________________________________________________________________________________
10. Supervision and Monitoring Team During this Visit Comprised the Following Officials:
Name ___________________ Designation _________________Dept/Division/Unit. __________a) 
Name ___________________ Designation _________________Dept/Division/Unit. __________b) 
Name ___________________ Designation _________________Dept/Division/Unit. __________c) 
Name ___________________ Designation _________________Dept/Division/Unit. __________d) 
Name ___________________ Designation _________________Dept/Division/Unit. __________e) 
Supervision and Monitoring Report was prepared by:
Name ______________________ Designation _________________Dept/Division/Unit. __________
Source: Kenya Health Information System. 2010. MOH Monthly Supervision and Monitoring Tool (DRH MOH).
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This table lists the indicators for FP commodities/EC pills (adapted from Reproductive Health, Sup-
plies Coalition, Monitoring and Evaluation Framework (2007–2015). The indicators are listed under 
each objective, broad goal and strategic area. 
INDICAToR METHoD oF CollECTIoN/VERIFICATIoN
Goal 1: Increase predictability and sustainability of financing for FP/EC supplies 
objective 1: Mobilize additional new resources
National budgetary line item for FP commodities i) 
including EC pills 
Government reports; MOH or MOF verification of budget 
line item
Increase in donor funding for FP commodities includ-ii) 
ing EC pills in the past 1–3 years 
Validated, procured, and paid for reproductive health sup-
plies from government records in the past 1–3 years
objective 2. Access existing resources in support of FP/EC Supplies
Proportion of the country’s health budget for FP com-•	
modities including EC pills actually spent in the last 3 
years 
Government reports; MOH or MOF verification of budget 
line item for RH supplies in the past 1–3 years
objective 3. Mobilize total market resources for FP/EC supplies
Examples of initiatives in the country for expanding a) 
the total market for FP commodities including EC pills
Market segmentation studies; PPPs; reports from partners 
such as PSI, among others
Increase in the non-public sector share of the market b) 
for condoms, pills including EC pills
Market surveys undertaken by social marketing partners on 
sales and others
Goal 2. Strengthen the capacity of health systems to sustain FP/EC supplies 
objective 1. Strengthen existing systems
A functional FP commodity committee or similar i) 
mechanisms for managing RH/FP supplies in place
Program reports on existence and performance of com-
modity security committees or taskforces
Levonorgestrel or equivalent products listed on the ii) 
national essential drug list
Verify from the national essential drugs list
Monitor the supply chain for ECPs in the public sector iii) 
at all levels periodically 
MOH program eports and those from key partners assisting 
governments with supply chain performance
objective 2. To avert RH supply disruptions at national level
Availability and use of guidelines/ procedures for •	
averting EC stock shortage
Minutes of the meetings/decisions taken and carried 
through
objective 3. Develop systems for emergency situations
Number of doses or units of dedicated ECPs issued to a) 
clients or distributed* in the last one complete year in 
both the public and private sector
Database at central warehouses in the public sector. 
Records of main EC brand distributors. Additional records 
could be obtained from other humanitarian agencies
Initiatives to integrate provision of FP/EC Pills into b) 
humanitarian relief efforts
Findings from studies undertaken; reports of
humanitarian efforts in RH supplies delivery
Goal 3: Steer EC mainstreaming activities within the broader RH services
objective 1. Foster greater harmonization among stakeholders at country level
Examples of coordinated action by partners •	 in a 
country, with the aim of strengthening the security of 
FP commodities/EC pills 
Narratives of instances from working groups, partners and 
country-led teams
objective 2. Promote new knowledge
Examples of all new tools, publications, and research i) 
initiatives produced in the past 1–3 years on EC 
mainstreaming work.
Routine collection of reports and initiatives by MOH and 
from partners
Annual increase in visits to the country’s RH/FP (or ii) 
equivalent) website
Website hit figures on FP commodities/EC pills and EC 
mainstreaming activities produced by Active Elements 
(website host)
objective 3. Establish support systems
Availability of an M&E report on performance of FP a) 
services including EC activities against baseline 
values in both public and private sectors
Analysis and evaluation of results of indicator changes
Identify sustainable ways of mainstreaming EC activi-b) 
ties into the broader RH activities
Minutes of the meetings
Routine collection of reports 
Records of supplies at services such as SGBV centers
*In functional partnerships, it is feasible to obtain this information from records of the main EC brand distributors.


